<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Bariatric operations: Early (fewer than 30 days) morbidity and mortality
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Bariatric operations: Early (fewer than 30 days) morbidity and mortality
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Bariatric operations: Early (fewer than 30 days) morbidity and mortality
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert B Lim, MD, FACS, FASMBS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel Jones, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 11, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H16611720">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bariatric operations are an effective method of reducing obesity and obesity-linked medical illnesses. They can be challenging due to the anatomic and physiologic characteristics and comorbidities of patients with obesity.
        </p>
        <p>
         This topic will review the major perioperative (intraoperative and early [≤30 day] postoperative) complications and mortality rates of common bariatric surgical procedures, including laparoscopic and open Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, biliopancreatic diversion with duodenal switch, and adjustable gastric banding. It will also include available data on the single-anastomosis duodenal ileal bypass with sleeve (SADI-S) and the one-anastomosis gastric bypass (OAGB).
        </p>
        <p>
         The bariatric procedures, indications and preoperative management, medical outcomes, and long-term complications of laparoscopic operations are reviewed in separate topics.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/88536.html" rel="external">
          "Bariatric procedures for the management of severe obesity: Descriptions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/586.html" rel="external">
          "Bariatric surgery for management of obesity: Indications and preoperative preparation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/90469.html" rel="external">
          "Outcomes of bariatric surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/585.html" rel="external">
          "Bariatric operations: Late complications with subacute presentations"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5483776">
         <span class="h1">
          INCIDENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serious intraoperative and early postoperative complications and mortality rates are relatively low when the surgery is performed by experienced surgeons at established bariatric centers.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intraoperative morbidity rates
         </strong>
         – In contemporary series, the overall rate of intraoperative complications from bariatric surgery ranges from 0.69 to 5 percent [
         <a href="#rid1">
          1-4
         </a>
         ]. The rate of intraoperative complications varies with the procedure [
         <a href="#rid1">
          1
         </a>
         ] (see
         <a class="local">
          'Intraoperative complications'
         </a>
         below):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         7.3 percent for open Roux-en-Y gastric bypass (RYGB).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         5.5 percent for laparoscopic RYGB.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         3.0 percent for laparoscopic adjustable gastric banding (AGB).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The rate for laparoscopic sleeve gastrectomy (SG) appears to be somewhere between that of laparoscopic RYGB and laparoscopic AGB [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The data regarding the rate of intraoperative complications for one-anastomosis gastric bypass (OAGB) are less robust, but it is estimated at 0.5 percent in one multicenter study [
         <a href="#rid6">
          6
         </a>
         ] and up to 4.63 percent in a single-center study [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The data for the single-anastomosis duodenal ileal bypass with sleeve (SADI-S) are limited to single-institution cohorts, in which no intraoperative complications were reported [
         <a href="#rid8">
          8,9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Early postoperative morbidity rates
         </strong>
         – The overall rate of a major complication occurring within 30 days ranges from approximately 0.2 to 10 percent in contemporary series [
         <a href="#rid4">
          4,10-15
         </a>
         ] and varies with the operative procedure, operative approach (open versus laparoscopic), and other factors [
         <a href="#rid13">
          13
         </a>
         ] (see
         <a class="local">
          'Postoperative surgical complications'
         </a>
         below and
         <a class="local">
          'Postoperative medical complications'
         </a>
         below):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The 30 day morbidity rate associated with laparoscopic SG is generally less than is seen with laparoscopic RYGB (0.8 to 5.6 versus 1.4 to 9.4 percent) [
         <a href="#rid5">
          5,16,17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The 30 day morbidity rate associated with laparoscopic RYGB is lower than that of open RYGB (3.4 versus 7.4 percent) [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Biliopancreatic diversion with duodenal switch (BPD-DS) appears to have the highest morbidity rates [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The 30 day morbidity rate associated with SADI-S is 2.65 [
         <a href="#rid18">
          18
         </a>
         ] to 3.3 [
         <a href="#rid8">
          8
         </a>
         ] percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The 30 day morbidity rate associated with OAGB is 5 percent [
         <a href="#rid19">
          19
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mortality rates
         </strong>
         – In a meta-analysis of 58 studies (3.6 million patients), the pooled mortality rate of bariatric surgery was 0.08 percent (95% CI 0.06-0.10) [
         <a href="#rid20">
          20
         </a>
         ]. Thirty-day, 90 day, in-hospital, and overall mortality rates were not statistically different, and neither were the mortality rates reported in trials, large cohort studies, or national registry/database studies. (See
         <a class="local">
          'Mortality'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         This has dramatically improved since the early 2000s and now compares favorably with the hospital mortality of other frequently performed major surgical procedures, including hip replacement (0.3 percent), abdominal aneurysm repair (3.9 percent), craniotomy (10.7 percent), esophageal resection (9.1 percent), and pancreatic resection (8.3 percent) [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The pooled mortality rates by procedure were [
         <a href="#rid20">
          20
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         0.03 percent for AGB
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         0.05 percent for laparoscopic SG
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         0.09 percent for OAGB
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         0.09 percent for RYGB
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         0.41 percent for BPD-DS
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         0.6 percent for SADI-S [
         <a href="#rid22">
          22
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Readmission and reoperation rates
         </strong>
         – Complications from bariatric operations may lead to rehospitalization and reoperation [
         <a href="#rid23">
          23-25
         </a>
         ]. In large database studies, the readmission rate has decreased from 5 percent [
         <a href="#rid26">
          26,27
         </a>
         ] between 2009 and 2015 to 2.75 percent between 2015 and 2018 [
         <a href="#rid28">
          28
         </a>
         ]. Short-term readmission rates are higher for RYGB than for other procedures such as SG [
         <a href="#rid13">
          13,28-30
         </a>
         ]. The OAGB has a similar rate of 5 percent [
         <a href="#rid31">
          31
         </a>
         ]. Hospital readmission rates are higher after open compared with laparoscopic procedures [
         <a href="#rid1">
          1,4,10,32,33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The rate of reoperation within 30 days of the initial procedure ranges from 0.7 to 7.6 percent [
         <a href="#rid4">
          4,26,34-37
         </a>
         ]. The reoperation rates tend to be higher with more complicated procedures, such as BPD-DS and the SADI-S. The rate is more than twice as much for the BPD-DS versus RYGB (3.3 versus 1.5 percent) [
         <a href="#rid4">
          4
         </a>
         ] and for the RYGB (0.7 to 5 percent) versus SG (0.5 to 3 percent) [
         <a href="#rid13">
          13,29,30
         </a>
         ]. The reoperation rate also tends to be higher with the laparoscopic versus the open approach (7.6 versus 6.6 percent) [
         <a href="#rid34">
          34
         </a>
         ]. The SADI-S appears to have a higher reoperation rate than the RYGB (5.0 versus 2.6 percent); however, the SADI-S also appeared to be used in patients with a higher body mass index (BMI), indicating a higher inherent risk [
         <a href="#rid22">
          22
         </a>
         ]. The reoperation rate for the OAGB is estimated at 1.01 percent [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Trend
         </strong>
         – In a 2022 registry-based analysis of 690,770 patients who underwent RYGB and SG between 2015 and 2019 at centers participating in the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP; 73 percent SG), there was a significant relative reduction in readmissions, end-organ dysfunction, and all-cause mortality in the SG subgroup [
         <a href="#rid39">
          39
         </a>
         ]. There were also noticeable reductions in 30 day readmission, intensive care unit admission, and end-organ dysfunction in the RYGB subgroup. For complications, bleeding, postoperative pneumonia, and stroke were significantly decreased in the RYGB subgroup, but only bleeding was significantly decreased in the SG subgroup during this five-year study period.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2840177333">
         <span class="h1">
          RISK FACTORS AND PREVENTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Higher postoperative complication rates are associated with certain procedures, approaches, and adverse intraoperative events. Certain steps can be taken pre-, intra-, or postoperatively to mitigate the higher risk [
         <a href="#rid1">
          1-3,10,40-43
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H302040598">
         <span class="h2">
          Risk factors for early postoperative morbidities
         </span>
         <span class="headingEndMark">
          —
         </span>
         General risk factors for early postoperative morbidities include the use of complex procedures, the use of the open approach, and acute intraoperative events (AIEs). A few studies have assessed risk factors for specific complications [
         <a href="#rid35">
          35,44-48
         </a>
         ]. They will be discussed below in the respective sections.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complexity of procedures
         </strong>
         – The morbidity rate is dependent upon the type of procedure performed [
         <a href="#rid4">
          4,10,49-60
         </a>
         ]. In general, biliopancreatic diversion with duodenal switch (BPD-DS) is associated with the highest morbidity rate [
         <a href="#rid49">
          49
         </a>
         ], while laparoscopic adjustable gastric banding (AGB) is associated with the lowest [
         <a href="#rid10">
          10
         </a>
         ]. Laparoscopic Roux-en-Y gastric bypass (RYGB) and laparoscopic sleeve gastrectomy (SG) have fewer complications than BPD-DS but more complications than laparoscopic AGB. Laparoscopic RYGB and laparoscopic SG have similar major complication rates, but laparoscopic RGYB is associated with more minor complications than SG [
         <a href="#rid50">
          50
         </a>
         ]. The single-anastomosis duodenal ileal bypass with sleeve (SADI-S) and one-anastomosis gastric bypass (OAGB) have early complication rates similar to those of the RYGB but also lower than those of the BPD-DS [
         <a href="#rid18">
          18,31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Open versus laparoscopic approach
         </strong>
         – The American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) database showed that patients who had undergone an open approach to an RYGB had significantly higher morbidity than those who underwent a laparoscopic one [
         <a href="#rid10">
          10,27
         </a>
         ]. The patients who had undergone a laparotomy had higher rates of major complications (7.4 versus 3.4 percent), more return visits to the operating room (4.9 versus 3.6 percent), and longer postoperative length of stay (median three versus two days) than patients who had laparoscopic RYGB [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intraoperative complications
         </strong>
         – An AIE, along with conversion from a laparoscopic to an open procedure, increases the risk for serious postoperative complications (eg, pulmonary embolus, myocardial infarction) [
         <a href="#rid1">
          1,2
         </a>
         ]. Patients who experience an AIE are more than twice as likely to develop a major postoperative complication compared with patients without an adverse event (8.8 versus 3.9 percent, p&lt;0.001).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1196432896">
         <span class="h2">
          Prevention of complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain steps can be taken prior to, during, and after bariatric operations to minimize complications.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H292030996">
         <span class="h3">
          Preoperative steps
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preoperative management of bariatric patient is discussed in another topic. (See
         <a class="medical medical_review" href="/z/d/html/586.html" rel="external">
          "Bariatric surgery for management of obesity: Indications and preoperative preparation"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative evaluation
         </strong>
         – A thorough preoperative assessment of comorbid illnesses (eg, diabetes, hypertension, cirrhosis, obstructive sleep apnea) and effective preoperative management as well as an assessment of anesthetic risks must be performed prior to the operative procedure. A higher risk of morbidity is noted in male bariatric patients, those with a body mass index (BMI) &gt;50 kg/m
         <sup>
          2
         </sup>
         , those with dysmetabolic syndrome, and those over age 65 [
         <a href="#rid47">
          47
         </a>
         ]. Immobile or functionally dependent patients, in particular, have a very high risk of complications [
         <a href="#rid61">
          61
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/586.html" rel="external">
          "Bariatric surgery for management of obesity: Indications and preoperative preparation", section on 'Preoperative assessment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative weight loss
         </strong>
         – There is evidence that a low- (800 to 1200 kcal) or very-low- (400 to 800 kcal) calorie diet for 2 to 12 weeks may induce sufficient weight loss to improve the technical ease of bariatric surgery by reducing the volume of the liver (by 15 to 30 percent) and overall adiposity [
         <a href="#rid62">
          62
         </a>
         ]. However, it is unclear whether preoperative weight loss can reduce the risks of 30 day postoperative complications [
         <a href="#rid63">
          63,64
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/586.html" rel="external">
          "Bariatric surgery for management of obesity: Indications and preoperative preparation", section on 'Preoperative weight loss'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Venous thromboembolic (VTE) prophylaxis
         </strong>
         – Prophylaxis against VTE following bariatric operations is discussed separately. (See
         <a class="local">
          'Venous thromboembolism'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H841279364">
         <span class="h3">
          Intraoperative steps
         </span>
         <span class="headingEndMark">
          —
         </span>
         Details of common bariatric procedures are discussed in other topics. (See
         <a class="medical medical_review" href="/z/d/html/109434.html" rel="external">
          "Laparoscopic Roux-en-Y gastric bypass"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/109435.html" rel="external">
          "Laparoscopic sleeve gastrectomy"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Instrument and equipment condition
         </strong>
         – Prior to the patient receiving an anesthetic, the surgeon and appropriate operating room personnel should examine all instruments for availability and function. The usual length of laparoscopic equipment is 38 cm long, but lengths up to 43 cm are available for laparoscopic instruments, surgical energy devices, and staplers. It would be important for the surgeon to know if their hospital has such equipment at its disposal. (See
         <a class="medical medical_review" href="/z/d/html/4874.html" rel="external">
          "Instruments and devices used in laparoscopic surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Proper placement of trocars
         </strong>
         – Torque that occurs from improperly placed trocars can be minimized by repositioning or adding additional ports. For example, for a patient with a very large abdomen, it may be difficult to access the gastroesophageal junction and infracolic abdomen to perform an RYGB anastomosis. In this setting, the use of additional ports would likely facilitate the procedure  (
         <a class="graphic graphic_figure graphicRef56074" href="/z/d/graphic/56074.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15103.html" rel="external">
          "Abdominal access techniques used in laparoscopic surgery", section on 'Foregut surgery'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tension-free anastomosis
         </strong>
         – Tension on the gastrojejunal anastomosis when performing an RYGB is a risk factor for anastomotic leak  (
         <a class="graphic graphic_figure graphicRef79256" href="/z/d/graphic/79256.html" rel="external">
          figure 2
         </a>
         ). A retrocolic, retrogastric approach creates the least amount of tension on the anastomosis  (
         <a class="graphic graphic_figure graphicRef70745" href="/z/d/graphic/70745.html" rel="external">
          figure 3
         </a>
         ). While the antecolic, antegastric route may be technically easier to perform, this route may also create a greater amount of tension on the anastomosis. Bariatric surgeons should be comfortable with performing both Roux limb routes. (See
         <a class="medical medical_review" href="/z/d/html/88536.html" rel="external">
          "Bariatric procedures for the management of severe obesity: Descriptions", section on 'Roux-en-Y gastric bypass'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Defining a plane between adhesions and bowel
         </strong>
         – Regardless of whether adhesions are lysed with an electrosurgical device or scissors, defining and maintaining a clear plane of dissection will minimize risk to the bowel wall. Prompt identification of injury and primary repair of the inadvertent laceration will minimize the risk of a subsequent leak. If the procedure cannot be safely performed laparoscopically because of dense adhesions, conversion to an open approach may enable better visualization and safer lysis of adhesions. (See
         <a class="medical medical_review" href="/z/d/html/88846.html" rel="external">
          "Complications of laparoscopic surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2378583051">
         <span class="h3">
          Postoperative steps
         </span>
         <span class="headingEndMark">
          —
         </span>
         Enhanced recovery after surgery (ERAS) protocols, also called fast-track protocols, are associated with shorter lengths of hospital stay and lower postoperative morbidity [
         <a href="#rid65">
          65
         </a>
         ]. Many ERAS protocols have the added benefit of avoiding the use of narcotics for postoperative pain control [
         <a href="#rid66">
          66,67
         </a>
         ]. ERAS protocols or care pathways have been published for bariatric surgery by major societies [
         <a href="#rid68">
          68-72
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5483849">
         <span class="h1">
          INTRAOPERATIVE COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common intraoperative complications for laparoscopic Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (AGB) operations, based upon the Longitudinal Assessment of Bariatric Surgery (LABS) database, include [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anesthesia events (1.0 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Instrument/equipment failure (0.8 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bowel injury (0.8 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatic injury (0.4 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anastomosis revision (0.3 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Splenic injury (0.2 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Major blood vessel injury (0.1 percent)
        </p>
        <p>
        </p>
        <p>
         Based upon the retrospective review of 504 patients in the Bariatric Outcomes Longitudinal Database (BOLD) database undergoing an open RYGB, the overall adverse intraoperative event rate was 7.3 percent [
         <a href="#rid1">
          1
         </a>
         ]. The most common adverse intraoperative complications for open procedures included:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Revision of anastomosis (2.0 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bowel injury (1.0 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Instrument/equipment failure (0.6 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anesthesia events (0.4 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatic injury (0.2 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Major blood vessel injury (0.2 percent)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1856073875">
         <span class="h2">
          Anesthetic events
         </span>
         <span class="headingEndMark">
          —
         </span>
         Operating on the individual with obesity can be technically challenging even for the most experienced anesthesia and surgical teams. The anatomic and physiologic characteristics of obesity are associated with difficult airway and drug management. The challenges and strategies of anesthetic management during bariatric surgery are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14932.html" rel="external">
          "Anesthesia for the patient with obesity"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1929627">
         <span class="h2">
          Laparoscopic access-related injuries
         </span>
         <span class="headingEndMark">
          —
         </span>
         Abdominal access can be challenging in the patient with a thick abdominal wall; however, all types of entry access can be safely performed by experienced surgeons [
         <a href="#rid73">
          73-76
         </a>
         ]. Based upon 17 randomized trials that included 3040 patients, there was no statistical difference in the rates of major complications (eg, vascular or solid organ injury) for open or closed (Veress needle, standard or optical trocar) laparoscopic entry techniques [
         <a href="#rid76">
          76
         </a>
         ]. Access techniques and access-related complications for laparoscopic procedures are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/15103.html" rel="external">
          "Abdominal access techniques used in laparoscopic surgery", section on 'Initial port placement'
         </a>
         .)
        </p>
        <p>
         Many bariatric surgeons prefer a combined approach. They first obtain pneumoperitoneum using the Veress needle technique through Palmer's point, then place a port in the left upper quadrant using an optical view method. Placing the patient in the 5 to 10 degree reverse Trendelenburg position may drop some of the intra-abdominal and subcutaneous fat into a more caudad and inferior position, allowing easier access to the upper abdomen.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         When using the Veress needle technique, the left upper quadrant is preferred for initial placement (Palmer's point). The aspiration test, the
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         drop test, and an opening pressure of less than 10 mmHg should all be used to confirm proper placement of the needle. The area beneath the Veress needle insertion site inside the abdomen should be inspected for injuries during the initial laparoscopic evaluation of the abdomen [
         <a href="#rid73">
          73-76
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         When using the Hassan technique for patients with a large amount of subcutaneous fat, the incision should be made large enough to identify the abdominal wall fascia and peritoneum.
        </p>
        <p>
        </p>
        <p>
         Many structures are at risk of injury, including major vessels and solid and hollow organs, during the introduction of the trocar or Veress needle. Some injuries can be life-threatening. In the supine position, the aorta and inferior vena cava are only 2 to 3 cm below the skin, so blind entry here can result in a major vascular injury. Bariatric patients tend to have a longer distance but may require more force to access the peritoneum because of the amount of subcutaneous tissue. Subsequently, they can still be at risk for vascular injuries.
        </p>
        <p>
         Bowel injury, such as a puncture or laceration, can occur with insertion of a Veress needle, trocar, lysis of adhesions, or dissection. (See
         <a class="medical medical_review" href="/z/d/html/88846.html" rel="external">
          "Complications of laparoscopic surgery", section on 'Bowel injuries'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/88846.html" rel="external">
          "Complications of laparoscopic surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3584701962">
         <span class="h2">
          Solid viscus organ injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         The liver and spleen can be injured during bariatric surgical procedures because of their close proximity to the stomach  (
         <a class="graphic graphic_figure graphicRef56689" href="/z/d/graphic/56689.html" rel="external">
          figure 4
         </a>
         ), especially during sleeve gastrectomy (SG)  (
         <a class="graphic graphic_picture graphicRef112056" href="/z/d/graphic/112056.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid77">
          77
         </a>
         ]. Bleeding can usually be controlled with suturing or hemostatic agents, and a partial hepatectomy or splenectomy is rarely required [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p>
         In addition, patients with cirrhosis, especially if found incidentally, have a higher risk of splenic vein bleeding, and consideration should be given to aborting the operation, especially if previously undiagnosed gastric varices are found. (See
         <a class="medical medical_review" href="/z/d/html/1263.html" rel="external">
          "Cirrhosis in adults: Overview of complications, general management, and prognosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13932.html" rel="external">
          "Hemostatic abnormalities in patients with liver disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/90896.html" rel="external">
          "Portal hypertension in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1930198">
         <span class="h2">
          Portal vein, inferior vena cava injuries
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraoperative injury to the portal vein and inferior vena cava is rare during bariatric operations but can lead to rapid exsanguination [
         <a href="#rid78">
          78
         </a>
         ]. If thrombosis of the portal vein occurs following an injury, it can lead to mesenteric venous thrombosis, and such patients may require liver transplantation [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/88846.html" rel="external">
          "Complications of laparoscopic surgery", section on 'Major vessels'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3579.html" rel="external">
          "Acute portal vein thrombosis in adults: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5489208">
         <span class="h2">
          Bowel ischemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         During the performance of RYGB or biliopancreatic diversion with duodenal switch (BPD-DS) procedures in particular, ischemia of the bowel may result if the root of the mesentery containing the major mesenteric vessels is compromised or undermined in one of the following scenarios [
         <a href="#rid79">
          79-82
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Twisting the mesentery and/or mesenteric root while creating a retrocolic pathway for the Roux limb
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Creating tension on the Roux limb when performing a gastrojejunal anastomosis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Incising the mesentery of the biliopancreatic limb or Roux limb at an angle such that blood flow to an end of intestinal limb is compromised
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Closing the mesenteric defect with overly generous amounts of tissue between sutures
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1283924088">
         <span class="h2">
          Misconstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Misconstruction of an RYGB or a BPD-DS  (
         <a class="graphic graphic_figure graphicRef54159" href="/z/d/graphic/54159.html" rel="external">
          figure 5
         </a>
         ) can occur during a laparoscopic or open approach. Proper bowel orientation must be maintained to avoid misconstruction.
        </p>
        <p>
         Misconstructions of the RYGB with an anastomosis between the distal aspect of the biliopancreatic limb and the gastric pouch have been reported and can lead to chronic bilious vomiting ("Roux-en-O")  (
         <a class="graphic graphic_diagnosticimage graphicRef57903" href="/z/d/graphic/57903.html" rel="external">
          image 1
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef65134" href="/z/d/graphic/65134.html" rel="external">
          image 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef62513" href="/z/d/graphic/62513.html" rel="external">
          figure 6
         </a>
         and
         <a class="graphic graphic_figure graphicRef77877" href="/z/d/graphic/77877.html" rel="external">
          figure 7
         </a>
         ) [
         <a href="#rid83">
          83
         </a>
         ]. Other examples of misconstruction include Roux limb inversion  (
         <a class="graphic graphic_diagnosticimage graphicRef75325" href="/z/d/graphic/75325.html" rel="external">
          image 3
         </a>
         and
         <a class="graphic graphic_figure graphicRef55376" href="/z/d/graphic/55376.html" rel="external">
          figure 8
         </a>
         ) and short Roux limb  (
         <a class="graphic graphic_figure graphicRef80144" href="/z/d/graphic/80144.html" rel="external">
          figure 9
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef68135" href="/z/d/graphic/68135.html" rel="external">
          image 4
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H56219551">
         <span class="h1">
          POSTOPERATIVE SURGICAL COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early (≤30 day) surgical complications include gastrointestinal leaks, hemorrhage, surgical site infections, marginal ulcers, anastomotic or sleeve stenosis, small bowel obstruction, oral intake intolerance, acute stoma obstruction after adjustable gastric banding (AGB), and portomesenteric vein thrombosis [
         <a href="#rid11">
          11,12,34,44,84-92
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H56220163">
         <span class="h2">
          Gastrointestinal leak
         </span>
         <span class="headingEndMark">
          —
         </span>
         An anastomotic or staple line leak remains the most dreaded technical complication of bariatric surgery [
         <a href="#rid12">
          12,34,85-90,93-98
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence
         </strong>
         – The risk of a leak ranges from 0.8 to 6 percent depending on the procedures chosen as well as technical and patient factors involved [
         <a href="#rid4">
          4,14,99-102
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         From a Roux-en-Y gastric bypass (RYGB), leaks can occur at the gastrojejunal or jejunojejunal anastomosis at a rate of approximately 1.0 percent [
         <a href="#rid100">
          100
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         From a sleeve gastrectomy (SG), leaks can occur at the staple line at a rate of up to 7 percent, but generally the rate has decreased to around 1.5 percent [
         <a href="#rid103">
          103
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         From a biliopancreatic diversion with duodenal switch (BPD-DS), leaks can occur from the anastomoses or from the long stomach staple line at a rate of 5 percent [
         <a href="#rid104">
          104
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         From a one-anastomosis gastric bypass (OAGB), leaks can occur at the gastrojejunal anastomosis at a rate of 1.8 percent [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         From a single-anastomosis duodenal ileal bypass with sleeve (SADI-S), leaks can occur at the duodeno-ileal anastomosis or from the long stomach staple line at a rate of 2.2 percent [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In revisional bariatric surgery, the risk of anastomotic leak approaches 35 percent [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Timing
         </strong>
         – Most leaks after bariatric surgery occur early, generally within the first week after surgery, but can be either before or after the patient has been discharged [
         <a href="#rid14">
          14
         </a>
         ]. Therefore, vigilant follow-up during the first 30 days is recommended.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Symptoms of a gastrointestinal leak include abdominal pain, oral intolerance, and a "feeling of doom." Sometimes the presentation can be subtle and require vigilance for signs such as low-grade fevers, respiratory compromise, and/or unexplained sustained tachycardia greater than 120 bpm [
         <a href="#rid105">
          105
         </a>
         ]. The same signs may also be present in the setting of pulmonary embolism. (See
         <a class="local">
          'Venous thromboembolism'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
         – A leak may be radiographically confirmed by
         <a class="drug drug_general" data-topicid="9180" href="/z/d/drug information/9180.html" rel="external">
          barium
         </a>
         swallow or contrast computed tomography (CT)  (
         <a class="graphic graphic_diagnosticimage graphicRef57699" href="/z/d/graphic/57699.html" rel="external">
          image 5
         </a>
         and
         <a class="graphic graphic_diagnosticimage graphicRef74948" href="/z/d/graphic/74948.html" rel="external">
          image 6
         </a>
         ) or intraoperatively at the time of surgical exploration [
         <a href="#rid106">
          106-110
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – The most important aspect of treatment is early recognition. Any patient with sustained tachycardia above 120 beats per minute should be admitted to the hospital, fluid resuscitated, and closely observed for worsening tachycardia, the development of sepsis, or hemodynamic instability, all conditions that would prompt surgical exploration with possible intraoperative endoscopy to rule out the leak definitively.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If a leak is suspected clinically in patients who are hemodynamically unstable, emergency surgical exploration should be performed, even if the imaging is negative, given that such patients can rapidly progress to sepsis [
         <a href="#rid109">
          109,111
         </a>
         ]. Multiple studies have shown that re-exploration is safe and avoids missing or delaying the treatment of a leak [
         <a href="#rid112">
          112-114
         </a>
         ]. In experienced hands, surgical exploration and management of a leak is often feasible via a laparoscopic approach. A negative exploration that does not reveal a leak should not be considered a complication due to the need for reoperation but rather evidence of good surgical judgment. The surgical principles in treating a leak include  (
         <a class="graphic graphic_figure graphicRef73658" href="/z/d/graphic/73658.html" rel="external">
          figure 10
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Broad-spectrum antibiotic coverage
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Identification and repair of the defect
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Irrigation and control of contamination
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Wide external drainage of the contaminated area
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Enteral access for feeding (eg, a gastric feeding tube placed in the gastric remnant for RYGB)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For hemodynamically stable patients who have a small, contained leak, radiology-guided placement of drainage catheters or endoscopic placement of clips, fibrin glue, stents, or negative pressure suction has all been used with success [
         <a href="#rid113">
          113,115-118
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2655.html" rel="external">
          "Gastrointestinal endoscopy in patients who have undergone bariatric surgery", section on 'Anastomotic leak and fistula'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Leaks from an SG generally take a longer time to close than leaks from other bariatric procedures. The sleeved stomach is a high-pressure system due to the presence of sphincters at both ends. The pressure may cause a leak to persist. Additionally, the leak may be caused by a stenosis in the sleeve, a kink in the sleeve's course, or a twist in the sleeve. Consequently, leaks may not close without alleviating the partial obstruction from these entities, which may ultimately require a reoperation [
         <a href="#rid119">
          119
         </a>
         ]. (See
         <a class="local">
          'Stenosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention
         </strong>
         – Many different intraoperative techniques have been used to decrease the incidence of leaks. Over-sewing staple lines, buttressing materials for the staple line, and fibrin glue have been used, but there is no evidence that these methods reliably decrease the leak rate after RYGB [
         <a href="#rid120">
          120-127
         </a>
         ] or SG [
         <a href="#rid128">
          128
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">
          Methylene blue
         </a>
         dye or endoscopy can be used intraoperatively to test for a leak during an RYGB or SG. For the dye test, methylene blue-tinged
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         is injected via the nasogastric tube while the bowel distal to the gastrojejunostomy is gently occluded. A leak is detected by the presence of methylene blue around the staple line. Alternatively, the pouch can be evaluated for a leak under direct visualization with an endoscope. For endoscopic evaluation, the gastrojejunostomy or sleeve is submerged in saline and the Roux limb or distal stomach is gently occluded, then the endoscope is used to insufflate the pouch. The presence of air bubbles in the saline around the pouch during insufflation indicates a leak may be present. Whether postoperative upper gastrointestinal series should be ordered routinely or selectively remains controversial and is discussed elsewhere [
         <a href="#rid106">
          106,109,110
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14953.html" rel="external">
          "Imaging studies after bariatric surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2436622301">
         <span class="h2">
          Hemorrhage
         </span>
         <span class="headingEndMark">
          —
         </span>
         Significant hemorrhaging after bariatric surgery has been described in 0.4 to 4.0 percent of patients [
         <a href="#rid10">
          10,12,15,34,85-90
         </a>
         ]. Bleeding can occur from the gastric or short gastric vessels during dissection of the greater curve. Most of the bleeding problems associated with an SG occur from the staple line after transection of the stomach [
         <a href="#rid53">
          53,129,130
         </a>
         ]. The bleeding is most likely a result of the large staples used for the thick tissue in the distal stomach. Large staples are not adequate to seal small vessels [
         <a href="#rid131">
          131
         </a>
         ]. This has led many surgeons to reinforce the staple line by over-sewing, buttressing, or both [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         Early bleeding can also occur from an anastomosis, which most commonly bleeds intraluminally. Patients frequently present with tachycardia, a decreased hematocrit, hematochezia, or melena [
         <a href="#rid91">
          91
         </a>
         ]. Such bleeding typically resolves without surgical intervention but may require transfusion of blood products and reversal of anticoagulation [
         <a href="#rid12">
          12,85,88
         </a>
         ]. Careful endoscopic examination and therapy is appropriate for ongoing bleeding with high transfusion requirements. (See
         <a class="medical medical_review" href="/z/d/html/2655.html" rel="external">
          "Gastrointestinal endoscopy in patients who have undergone bariatric surgery", section on 'Gastrojejunal ulceration and bleeding'
         </a>
         .)
        </p>
        <p>
         Surgery is reserved for hemodynamic instability, intraluminal bleeding not amenable to endoscopic therapy (eg, staple line of the excluded stomach), extraluminal bleeding, or continued bleeding despite restoration of normal coagulation status [
         <a href="#rid91">
          91,92
         </a>
         ]. Patients with early postoperative bleeding had a longer hospital admission (4.8 versus 3.0 days, p&lt;0.001) and a higher mortality rate (7.1 versus 0.9 percent, p&lt;0.01) compared with patients without an early bleed [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H646703830">
         <span class="h2">
          Surgical site infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         The Bariatric Outcomes Longitudinal Database (BOLD) study reported an overall incidence of surgical site infection (SSI) of 1.1 percent [
         <a href="#rid4">
          4
         </a>
         ]. Rates of wound infection are significantly greater for open gastric bypass procedures (10 to 15 percent) compared with laparoscopic (3 to 4 percent) procedures [
         <a href="#rid34">
          34,78,85
         </a>
         ].
        </p>
        <p>
         Signs of wound infections include unexplained fever, fluctuance, erythema, or drainage. Treatment consists of opening the affected area for drainage of infected fluid or pus, debridement of any devitalized tissue, and antibiotics if the surrounding skin suggests signs of cellulitis. (See
         <a class="medical medical_review" href="/z/d/html/1.html" rel="external">
          "Complications of abdominal surgical incisions"
         </a>
         .)
        </p>
        <p>
         The incidence of wound infections can be decreased by perioperative administration of antibiotics. Data support the use of
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         , or in patients allergic to penicillins and cephalosporins,
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         PLUS one of the following:
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         ,
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         , or
         <a class="drug drug_general" data-topicid="9047" href="/z/d/drug information/9047.html" rel="external">
          aztreonam
         </a>
         [
         <a href="#rid132">
          132
         </a>
         ]. The choice of antibiotics is reviewed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13984.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection following gastrointestinal procedures in adults", section on 'Gastroduodenal procedures'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H324396369">
         <span class="h2">
          Marginal ulcers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Marginal ulcers typically occur within 30 days after the RYGB operations at the gastrojejunal anastomosis  (
         <a class="graphic graphic_picture graphicRef66371" href="/z/d/graphic/66371.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid133">
          133
         </a>
         ] and at the gastroileal junction following a BPD-DS [
         <a href="#rid134">
          134
         </a>
         ], despite bypass or removal of most of the acid-secreting cells of the stomach. The risk of a marginal ulcer following bariatric operations based upon the BOLD study was 1.2 percent [
         <a href="#rid4">
          4
         </a>
         ]. The incidence of a marginal ulcer following a BPD-DS was 0.3 percent [
         <a href="#rid134">
          134
         </a>
         ], while the incidence of a marginal ulcer following a BPD only was 3 percent [
         <a href="#rid135">
          135
         </a>
         ].
        </p>
        <p>
         The clinical presentation of marginal ulcers includes melena, hematochezia, hematemesis, or pain and obstructive symptoms as the swollen mucosa can occlude the anastomosis to the small intestine [
         <a href="#rid136">
          136
         </a>
         ]. Early ulceration most likely is related to ischemia, too large of a pouch, or undiagnosed
         <em>
          Helicobacter pylori
         </em>
         infection. (See
         <a class="medical medical_review" href="/z/d/html/16.html" rel="external">
          "Bacteriology and epidemiology of Helicobacter pylori infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/18.html" rel="external">
          "Indications and diagnostic tests for Helicobacter pylori infection in adults"
         </a>
         .)
        </p>
        <p>
         Risk factors for a marginal ulcer include smoking, nonsteroidal anti-inflammatory drugs (NSAIDs), and gastrogastric fistula formation. Most surgeons will place their patients on a proton-pump inhibitor for 3 to 12 months after surgery to help prevent the occurrence of marginal ulcers. Lifetime avoidance of smoking and NSAIDs is advised in RYGB and BPD-DS patients as marginal ulcers can also develop as a late complication. (See
         <a class="medical medical_review" href="/z/d/html/585.html" rel="external">
          "Bariatric operations: Late complications with subacute presentations"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4067813801">
         <span class="h2">
          Stenosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Stenosis occurs when the gastrojejunal anastomosis of an RYGB or gastroileal anastomosis of a BPD-DS becomes occluded secondary to tissue edema or a narrow anastomosis. Following an SG, stenosis can occur if the sleeve narrows, kinks, or twists. A retrospective review of 230 patients found that the risk of stenosis following an RYGB, a BPD-DS, or an SG is approximately 3.3, 1.2, and 3.5 percent, respectively [
         <a href="#rid137">
          137
         </a>
         ]. Another study of over 180,000 patients from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database reported that the overall incidence of early gastrojejunal stricture after RYGB (within 30 days) was 4.7 per 1000 person-years, of which 85, 40, and 5.6 percent required therapeutic intervention, readmission, and reoperation, respectively [
         <a href="#rid138">
          138
         </a>
         ].
        </p>
        <p>
         The clinical presentation is consistent with an obstruction and includes nausea, vomiting, abdominal pain, and dysphagia. Endoscopic balloon dilation of the stenotic structures, including those resulting from an SG, is the first management option. [
         <a href="#rid118">
          118
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2655.html" rel="external">
          "Gastrointestinal endoscopy in patients who have undergone bariatric surgery", section on 'Stomal (anastomotic) stenosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1878198527">
         <span class="h2">
          Small bowel obstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Small bowel obstruction (SBO) can occur from misconstruction during RYGB or BPD-DS operations, internal herniation, adhesion formation (in both open and laparoscopic procedures), or port site hernia. Early SBO is usually caused by a technical error such as the failure to reapproximate the fascia from a port site or potential internal hernia sites. After an RYGB, an internal hernia can occur through the mesentery of the jejunojejunal anastomosis and posterior to the gastrojejunal anastomosis. If a retrocolic approach is used, an internal hernia can occur through the transverse mesocolon defect and through Petersen's defect, which is the space between the transverse mesocolon and the Roux limb as it passes through the mesocolon [
         <a href="#rid139">
          139
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/585.html" rel="external">
          "Bariatric operations: Late complications with subacute presentations"
         </a>
         .)
        </p>
        <p>
         In a prospective study that included 2126 patients undergoing RYGB, early SBO (within 30 days) following bariatric procedures occurred in approximately 0.5 percent of patients [
         <a href="#rid140">
          140
         </a>
         ]. Among 184,660 patients undergoing RYGB in the MBSAQIP database, 1189 (0.64 percent) required readmission due to SBO within 30 days, of which 69 percent required a reoperation and 1.3 percent expired [
         <a href="#rid141">
          141
         </a>
         ]. The reasons for readmission were identified as unspecified intestinal obstruction (82.5 percent), incisional hernia (9.1 percent), and internal hernia (8.4 percent). The SADI-S appears to have fewer SBOs than the BPD-DS [
         <a href="#rid18">
          18
         </a>
         ]. For the OAGB, the rate of bowel obstruction appears to be about 2.8 percent [
         <a href="#rid142">
          142
         </a>
         ].
        </p>
        <p>
         The clinical presentation and management of an SBO is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/8037.html" rel="external">
          "Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89300.html" rel="external">
          "Management of small bowel obstruction in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H398722777">
         <span class="h2">
          Nausea, vomiting, and poor oral intake
         </span>
         <span class="headingEndMark">
          —
         </span>
         After bariatric surgery, it is not unusual for patients to experience some extent of nausea, vomiting, and mild food intolerance [
         <a href="#rid29">
          29
         </a>
         ]. Generally, though, if patients can stay hydrated and tolerate a thin liquid diet, they will not need readmission or workup for the other causes of early morbidities. Patients with mild gastrointestinal symptoms are generally kept on a liquid diet for one to two weeks after the operation and slowly transition to more solid forms of food over the next one to two months. Surgical edema is typically the cause of these symptoms, which should be self-limited. Patients who continue to present with recurring or worsening symptoms should undergo further workup for more serious complications as discussed above.
        </p>
        <p class="headingAnchor" id="H401187896">
         <span class="h2">
          Stomal obstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute stomal obstruction is an early complication that can occur in up to 14 percent of AGB patients [
         <a href="#rid143">
          143-145
         </a>
         ]. Obstruction is usually caused by inclusion of excess perigastric fat, use of a band of insufficient diameter for the thickness of the tissue, or significant tissue edema. Patients usually present with persistent nausea, vomiting, and inability to tolerate secretions or oral intake. The diagnosis is confirmed with an upper gastrointestinal series demonstrating no passage of contrast beyond the band.
        </p>
        <p>
         Acute stomal obstruction due to edema can initially be treated conservatively with nasogastric tube decompression until the edema subsides, although the potential for aspiration pneumonia and gastric ischemia exists [
         <a href="#rid146">
          146
         </a>
         ]. Persistent obstruction requires surgical revision or removal of the band. Meticulous removal of excess perigastric fat at the time of initial band placement may help prevent this complication [
         <a href="#rid147">
          147
         </a>
         ]. The use of larger-diameter bands may also help to reduce the incidence of acute postoperative obstruction.
        </p>
        <p class="headingAnchor" id="H3183544462">
         <span class="h2">
          Portal, splenic, and mesenteric vein thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Portomesenteric vein thrombosis is a rare complication of laparoscopic bariatric surgery, most commonly after SG. The risk is about 0.4 percent, and it may lead to increased mortality. Patients typically present with abdominal pain, nausea, vomiting, fevers, tachycardia, and leukocytosis. Diagnosis can be made by CT scan of the abdomen [
         <a href="#rid148">
          148-150
         </a>
         ]. Therapy typically consists of anticoagulation therapy. (See
         <a class="medical medical_review" href="/z/d/html/109435.html" rel="external">
          "Laparoscopic sleeve gastrectomy", section on 'Portal vein thrombosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1572541271">
         <span class="h1">
          POSTOPERATIVE MEDICAL COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early (≤30 day) medical complications include deep vein thrombosis, pulmonary embolism, myocardial infarction, and pulmonary complications.
        </p>
        <p class="headingAnchor" id="H56221568">
         <span class="h2">
          Venous thromboembolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         Based upon information from multiple databases, the overall incidence of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), ranges from 0.17 to 0.4 percent [
         <a href="#rid3">
          3,151
         </a>
         ]. Furthermore, most VTEs occurred following discharge; 2 percent occurred intraoperatively, and 25 percent occurred prior to hospital discharge.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence
         </strong>
         – The rate of VTE identified in patients undergoing a Roux-en-Y gastric bypass (RYGB) and adjustable gastric banding (AGB) was 0.46 and 0.14 percent, respectively. The highest rates of VTE were identified in 4 percent of patients undergoing a biliopancreatic diversion (BPD) and 2.2 percent of patients undergoing a BPD with duodenal switch (BPD-DS). The incidence of VTE was 0.29 percent for laparoscopic procedures and 1.2 percent for open procedures [
         <a href="#rid152">
          152
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – Risk factors for VTEs include body mass index (BMI) &gt;50 kg/m
         <sup>
          2
         </sup>
         , a history of VTE, a history of a hypercoagulable disorder, pulmonary hypertension, venous stasis disease, poor functional status, open or revision surgery, and operative time &gt;3 hours [
         <a href="#rid151">
          151,153,154
         </a>
         ]. The most common risk factors associated with fatal PE include severe venous stasis disease, BMI &gt;60 kg/m
         <sup>
          2
         </sup>
         , truncal obesity, and obesity-hypoventilation syndrome [
         <a href="#rid154">
          154,155
         </a>
         ]. Patients undergoing revision bariatric surgery are at a higher risk of VTE [
         <a href="#rid152">
          152
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
         – Diagnosis of PE in patients with obesity can be problematic because the use of standard diagnostic modalities (such as a nuclear lung scan, computed tomographic [CT] angiography, pulmonary angiography, and/or lower extremity duplex scan) may not be physically feasible.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – Immediate anticoagulation is prescribed for patients for whom there is a high level of clinical suspicion. In patients in whom anticoagulation is contraindicated, a mechanical filter can be placed in the inferior vena cava to lower the risk of continued clot embolization (see
         <a class="medical medical_review" href="/z/d/html/8212.html" rel="external">
          "Placement of vena cava filters and their complications"
         </a>
         ). However, per the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) data, the use of an inferior vena cava (IVC) filter even in high-risk patients did not seem to have a protective benefit [
         <a href="#rid156">
          156
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention
         </strong>
         – A single optimal strategy for preventing VTE in the bariatric surgery setting has not been established [
         <a href="#rid157">
          157
         </a>
         ]. Most bariatric surgeons use both pneumatic compression devices in conjunction with subcutaneous unfractionated or low-molecular-weight heparin and ambulation on the day of surgery [
         <a href="#rid158">
          158
         </a>
         ]. The current American Society of Bariatric and Metabolic Surgeons (ASMBS) guidelines regarding thromboprophylaxis state that all bariatric patients receive mechanical prophylaxis and are ordered for early ambulation. Additionally, the surgeon may routinely use pharmacologic prophylaxis of either low-molecular-weight heparin or
         <a class="drug drug_general" data-topicid="8518" href="/z/d/drug information/8518.html" rel="external">
          unfractionated heparin
         </a>
         [
         <a href="#rid159">
          159
         </a>
         ]. In one retrospective study of over 24,000 patients undergoing bariatric procedures, low-molecular-weight heparin was more effective than unfractionated heparin in preventing postoperative VTE while not increasing the rate of bleeding [
         <a href="#rid160">
          160
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Preoperative risk stratification may be a useful tool for identifying high-risk patients for more aggressive prophylaxis [
         <a href="#rid161">
          161
         </a>
         ]. In patients identified preoperatively as high risk for PE, due to previous medical history of VTE, PE, or venous stasis disease or inability to ambulate, perioperative chemoprophylaxis of low-molecular-weight heparin or
         <a class="drug drug_general" data-topicid="8518" href="/z/d/drug information/8518.html" rel="external">
          unfractionated heparin
         </a>
         may be prescribed for an extended period even after discharge from the hospital. As the average time to developing VTE is 21 to 28 days, many bariatric surgeons continue chemoprophylaxis for six weeks postoperatively. The use of preoperatively placed IVC filters is associated with higher rates of VTE, PE, other complications, and death. Their routine use is discouraged [
         <a href="#rid162">
          162
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Prevention of postoperative VTE is reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">
          "Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1335.html" rel="external">
          "Prevention of venous thromboembolism in adults undergoing hip fracture repair or hip or knee replacement"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H56221790">
         <span class="h2">
          Myocardial infarction
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of a postoperative myocardial infarction after a bariatric operation is approximately 0.2 percent [
         <a href="#rid10">
          10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/69.html" rel="external">
          "Perioperative myocardial infarction or injury after noncardiac surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H56221822">
         <span class="h2">
          Pulmonary complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Major postoperative pulmonary complications include pneumonia and acute respiratory failure. Atelectasis is common after all types of surgery that require general anesthesia and is more prevalent in patients with obesity.
        </p>
        <p>
         The following studies illustrate the incidence rates and risks for pulmonary complications and the sequelae:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Based upon a retrospective review of the Bariatric Outcomes Longitudinal Database (BOLD) database, the overall incidence of postoperative pneumonia was 0.4 percent [
         <a href="#rid4">
          4
         </a>
         ]. The incidence of pneumonia was significantly higher for patients treated with a BPD-DS (n = 1545) compared with patients treated with RYGB (0.9 versus 0.4 percent, p = 0.001).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective review of the National Inpatient Sample database that included 304,515 patients undergoing a bariatric operation, the overall rate of acute respiratory failure (ARF) was 1.35 percent [
         <a href="#rid163">
          163
         </a>
         ]. The incidence was higher with an open compared with a laparoscopic procedure (3.87 versus 0.94 percent); RYGB compared with non-RYGB procedures (1.54 versus 0.82 percent); and for patients with preoperative heart failure, chronic renal failure, peripheral vascular disease, chronic obstructive pulmonary disease (COPD), tobacco smoking, and diabetes. ARF is associated with a significantly higher in-hospital mortality rate compared with those who do not develop the complication (5.69 versus 0.04 percent). (See
         <a class="local">
          'Mortality'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective review of the American College of Surgeons' National Surgical Quality Improvement Program that included 32,889 bariatric surgical patients, the incidence of pneumonia and ARF was 0.6 percent each [
         <a href="#rid164">
          164
         </a>
         ]. While the incidence is relatively low, patients with pulmonary complications were more likely to have additional in-hospital complications (eg, surgical site infections, PE, myocardial infarction), and length of stay was significantly longer (six versus three days, median length of stay). The 30 day mortality rate for patients with pneumonia and ARF was significantly higher compared with patients without the complication (4.3 versus 0.16 percent and 13.7 versus 0.10 percent, respectively). (See
         <a class="local">
          'Mortality'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Specific risk factors for pneumonia included new or preoperative medical history of heart failure, COPD, bleeding disorder, tobacco smoking history, increasing age, open versus laparoscopic operation, and RYGB and BPD-DS when compared with AGB.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Specific risk factors for ARF included COPD, percutaneous coronary intervention, diabetes, increasing age, prolonged anesthetic time, open versus laparoscopic operation, and RYGB and BPD-DS when compared with AGB.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Similarly, risk factors for pulmonary disease based upon the findings from the National Inpatient Sample database that included 304,515 patients included open procedures and comorbid factors that included heart failure, chronic renal failure, gastric bypass, peripheral vascular disease, male sex, age older than 50 years, alcohol drinking, smoking, chronic lung disease, and diabetes [
         <a href="#rid163">
          163
         </a>
         ]. Patients undergoing a revision bariatric procedure also have a high risk of morbidity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Early ambulation and incentive spirometry after surgery are important for decreasing the incidence of pulmonary complications. Preoperative identification of the presence of significant obstructive sleep apnea and initiation of continuous positive airway pressure (CPAP) therapy also reduce the risk of pulmonary complications in the postoperative period [
         <a href="#rid165">
          165
         </a>
         ]. CPAP should be used in the early postoperative period if it is clinically necessary without concern for causing a leak. (See
         <a class="medical medical_review" href="/z/d/html/4401.html" rel="external">
          "Overview of the management of postoperative pulmonary complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">
          "Clinical presentation and diagnosis of obstructive sleep apnea in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H56222222">
         <span class="h1">
          MORTALITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mortality rates are higher for patients undergoing more complex operative procedures or those who sustain adverse intraoperative events or serious in-hospital complications (such as pulmonary embolism [PE] or acute respiratory failure [ARF]) as well as those with a body mass index (BMI) ≥50 kg/m
         <sup>
          2
         </sup>
         , male sex, age ≥65, medical comorbidities, or poor functional status [
         <a href="#rid10">
          10,34,44,84,164,166-179
         </a>
         ]. In addition, the mortality rate was higher for patients undergoing an open (versus laparoscopic) procedure (0.79 versus 0.17 percent) [
         <a href="#rid10">
          10
         </a>
         ] or undergoing bariatric surgery by a low-volume surgeon or at a low-volume hospital.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complexity of procedure
         </strong>
         – Higher mortality rates were identified for patients undergoing the more complex biliopancreatic diversion with duodenal switch (BPD-DS) compared with adjustable gastric banding (AGB; 1.2 versus 0.3 percent) [
         <a href="#rid34">
          34
         </a>
         ]. (See
         <a class="local">
          'Incidence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Serious intraoperative or in-hospital complications
         </strong>
         – Higher mortality rates are also identified for patients with postoperative PE (7.1 percent) [
         <a href="#rid151">
          151
         </a>
         ], pneumonia (4.3 percent) or respiratory failure (13.7 percent) [
         <a href="#rid164">
          164
         </a>
         ], or sepsis (n = 6; 33 percent of all deaths) [
         <a href="#rid168">
          168
         </a>
         ] with respect to those patients without such complications. Additionally, complications of an anastomotic leak also increase the risk of postoperative mortality [
         <a href="#rid164">
          164
         </a>
         ]. If not diagnosed in a timely fashion, the mortality rate from an anastomotic leak can be as high as 15 percent [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         PE remains the most common cause of mortality in the perioperative period after bariatric surgery and accounts for approximately 30 to 50 percent of deaths [
         <a href="#rid84">
          84,180
         </a>
         ]. The mortality rate of a PE is dependent upon the severity of presentation and time to diagnosis/treatment and varies widely from 1 to 95 percent [
         <a href="#rid181">
          181
         </a>
         ]. The majority of deaths occur within the first one to two hours after the embolism. (See
         <a class="medical medical_review" href="/z/d/html/8253.html" rel="external">
          "Epidemiology and pathogenesis of acute pulmonary embolism in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8265.html" rel="external">
          "Treatment, prognosis, and follow-up of acute pulmonary embolism in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiac complications, including myocardial infarction and cardiac failure, are a common cause of mortality in the perioperative period [
         <a href="#rid171">
          171,182
         </a>
         ]. An analysis of 13,871 patients from a national registry of bariatric surgery reported that the mortality from cardiovascular events ranged from 12.5 to 17.6 percent [
         <a href="#rid182">
          182
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6615.html" rel="external">
          "Management of cardiac risk for noncardiac surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ARF accounts for approximately 11 percent of perioperative mortality after bariatric operations [
         <a href="#rid96">
          96,182
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4401.html" rel="external">
          "Overview of the management of postoperative pulmonary complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sepsis related to an anastomotic leak, if not diagnosed in a timely fashion, is associated with a mortality rate as high as 15 percent [
         <a href="#rid99">
          99
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1657.html" rel="external">
          "Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patient-specific factors
         </strong>
         – Based upon retrospective reviews of United States (US) national databases and other series, the following examples illustrate patient-specific risk factors for mortality:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Male sex – Data from the National Inpatient Sample database on 304,515 patients showed that male sex (odds ratio 1.7) was associated with greater mortality [
         <a href="#rid174">
          174
         </a>
         ]. In a Medicare study, males had higher rates of early death than females at 30 days (3.7 versus 1.5 percent), 90 days (4.8 versus 2.1 percent), and one year (7.5 versus 3.7 percent) [
         <a href="#rid167">
          167
         </a>
         ]. Similar results have been reported in a large population-based study [
         <a href="#rid176">
          176
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Older age – Higher mortality rates have been reported in patients over the age of 65 years. A study of 16,155 Medicare beneficiaries who underwent bariatric procedures reported 30 day, 90 day, and one-year mortality rates of 2.0, 2.8, and 4.6 percent, respectively [
         <a href="#rid167">
          167
         </a>
         ]. Mortality rates were significantly higher for those aged 65 and older compared with younger patients (4.8 versus 1.7 percent at 30 days, 6.9 versus 2.3 percent at 90 days, and 11.1 versus 3.9 percent at one year). Similar results were reported in a second study of a similar population [
         <a href="#rid175">
          175
         </a>
         ]. This is also confirmed by the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database analysis of over 266,000 patients [
         <a href="#rid183">
          183
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Excessive obesity – There are conflicting reports relating excessive (or super) obesity to postoperative mortality. In a retrospective review of 856 patients undergoing bariatric surgery, patients who died (n = 54) were more likely to have a BMI ≥50 kg/m
         <sup>
          2
         </sup>
         compared with patients who survived (30/54 patients [55.6 percent] versus 278/802 patients [34.7 percent], hazard ratio [HR] 1.8, 95% CI 1.01-3.09) [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         However, in another retrospective review, BMI ≥60 kg/m
         <sup>
          2
         </sup>
         was not a risk factor for postoperative mortality. A review of 3692 patients undergoing a bariatric operation found that 291 patients with a BMI ≥60 kg/m
         <sup>
          2
         </sup>
         had a similar in-hospital mortality rate compared with patients with a BMI &lt;60 kg/m
         <sup>
          2
         </sup>
         (0.34 versus 0.12 percent) [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Comorbid illnesses – A diagnostic cost group (DCG) score is a risk adjustment measure that reflects the level of medical comorbidities and one-year mortality rates and predicts health expenditures in US veterans [
         <a href="#rid177">
          177-179
         </a>
         ]. In the retrospective study previously described [
         <a href="#rid44">
          44
         </a>
         ], DCG score ≥2 (higher-than-average expected expenditures) was significantly associated with an increased risk of death after bariatric surgery compared with a DCG score &lt;2 (HR 3.4, 95% CI 1.8-6.5). Metabolic syndrome is associated with three times the mortality compared with patients who do not have metabolic syndrome [
         <a href="#rid184">
          184,185
         </a>
         ]. Cirrhosis is also associated with an increased risk of mortality. Based upon the US Nationwide Inpatient Sample, patients without cirrhosis had significantly lower mortality rates compared with patients with compensated and decompensated cirrhosis (0.3 versus 0.9 versus 16.3 percent) [
         <a href="#rid186">
          186
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Poor functional status – Functional status is an underappreciated comorbidity of obesity as well as a predictor of postoperative complications. Functional status can be described as independent, partially dependent, and completely dependent. A totally dependent person needs assistance for all activities of daily living. A retrospective review of 44,408 bariatric surgery patients from the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) database from 2007 to 2009 found the overall mortality rate was 0.14 percent [
         <a href="#rid187">
          187
         </a>
         ]. For patients with partially dependent preoperative function, the adjusted odds ratio (AOR) for 30 day mortality was increased 2.6-fold, while totally dependent patients had a very high risk with an increased AOR of 27.6.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Surgeon-/hospital-specific factors
         </strong>
         – The following examples illustrate surgeon- or hospital-specific factors that contribute to a higher mortality:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Low-volume surgeons and hospitals – Increased mortality is associated with low surgeon and hospital volume of bariatric procedures. Both in-hospital and 30 day mortality are decreased when bariatric surgery is performed by surgeons and hospitals that perform more than 100 procedures a year [
         <a href="#rid166">
          166,176
         </a>
         ]. For these reasons, volume is one of the criteria utilized by the American Society of Metabolic and Bariatric Surgery and the ACS for the accreditation of bariatric center of excellence (COE) programs. Currently, a minimum of 50 stapling cases per year is required to be certified as a comprehensive bariatric COE by the governing bodies. (See
         <a class="medical medical_review" href="/z/d/html/14947.html" rel="external">
          "Hospital accreditation, accommodations, and staffing for care of the bariatric surgical patient", section on 'Surgeons and case volume'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Surgical approach – Improvements in perioperative mortality have been documented with the introduction of laparoscopic and robot-assisted techniques [
         <a href="#rid10">
          10,188-190
         </a>
         ]. Most series report a lower mortality rate with a laparoscopic versus an open approach, although mortality rates for both are less than 1 percent [
         <a href="#rid10">
          10
         </a>
         ]. The increased mortality with the open approach may be related to technical challenges that made the patient ineligible for the laparoscopic approach, adverse intraoperative events, and/or laparoscopic expertise of the surgeon [
         <a href="#rid37">
          37
         </a>
         ]. There is no difference between a laparoscopic and a robot-assisted laparoscopic approach in terms of morbidity and mortality.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1695499043">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112687.html" rel="external">
          "Society guideline links: Bariatric surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16616778">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence
         </strong>
         – When performed by experienced surgeons at established bariatric centers, the risk of serious intraoperative and early (≤30 days) postoperative complications and mortality rates are relatively low (see
         <a class="local">
          'Incidence'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intraoperative complication rate – 0.69 to 5 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Early postoperative complication rate – 0.2 to 10 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Perioperative mortality rate – 0.08 percent (95% CI 0.06-0.10)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Early readmission rate – 2.75 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Early reoperation rate – 0.7 to 7.6 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors and prevention
         </strong>
         – Higher postoperative complication rates are expected with more complex procedures, an open approach, and the occurrence of adverse intraoperative events. Certain steps can be taken pre-, intra-, or postoperatively to mitigate the higher risks. (See
         <a class="local">
          'Risk factors and prevention'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intraoperative complications
         </strong>
         – The most common intraoperative complications include anesthetic events, access-related injuries, liver or splenic injuries, vascular injuries, bowel ischemia, and anastomotic misconstruction. (See
         <a class="local">
          'Intraoperative complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Early postoperative surgical complications
         </strong>
         – Early (≤30 day) surgical complications include gastrointestinal leaks, hemorrhage, surgical site infections, marginal ulcers, anastomotic or sleeve stenosis, small bowel obstruction, oral intake intolerance, acute stoma obstruction after adjustable gastric banding (AGB), and portomesenteric vein thrombosis. (See
         <a class="local">
          'Postoperative surgical complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Early postoperative medical complications
         </strong>
         – Early (≤30 day) medical complications include deep vein thrombosis, pulmonary embolism, myocardial infarction, and pulmonary complications. (See
         <a class="local">
          'Postoperative medical complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mortality
         </strong>
         – Higher mortality rates are expected with (see
         <a class="local">
          'Mortality'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         More complex operative procedures (eg, biliopancreatic diversion with duodenal switch)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adverse intraoperative events or serious in-hospital complications (eg, pulmonary embolism, myocardial infarction, acute respiratory failure, or sepsis from a leak)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patient-specific risk factors such as body mass index ≥50 kg/m
         <sup>
          2
         </sup>
         , male sex, age ≥65, medical comorbidities, or poor functional status
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Use of the open (as opposed to minimally invasive) approach
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Low-volume surgeon or low-volume hospital
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Greenstein AJ, Wahed AS, Adeniji A, et al. Prevalence of adverse intraoperative events during obesity surgery and their sequelae. J Am Coll Surg 2012; 215:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stenberg E, Szabo E, Agren G, et al. Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry. Ann Surg 2014; 260:1040.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guerrier JB, Dietch ZC, Schirmer BD, Hallowell PT. Laparoscopic Sleeve Gastrectomy Is Associated with Lower 30-Day Morbidity Versus Laparoscopic Gastric Bypass: an Analysis of the American College of Surgeons NSQIP. Obes Surg 2018; 28:3567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson DW, Blair KS, Martin MJ. Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity. Arch Surg 2012; 147:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011; 254:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Musella M, Susa A, Manno E, et al. Complications Following the Mini/One Anastomosis Gastric Bypass (MGB/OAGB): a Multi-institutional Survey on 2678 Patients with a Mid-term (5 Years) Follow-up. Obes Surg 2017; 27:2956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rheinwalt KP, Plamper A, Rückbeil MV, et al. One Anastomosis Gastric Bypass-Mini-Gastric Bypass (OAGB-MGB) Versus Roux-en-Y Gastric Bypass (RYGB)-a Mid-Term Cohort Study with 612 Patients. Obes Surg 2020; 30:1230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pennestrì F, Sessa L, Prioli F, et al. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S): experience from a high-bariatric volume center. Langenbecks Arch Surg 2022; 407:1851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finno P, Osorio J, García-Ruiz-de-Gordejuela A, et al. Single Versus Double-Anastomosis Duodenal Switch: Single-Site Comparative Cohort Study in 440 Consecutive Patients. Obes Surg 2020; 30:3309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lancaster RT, Hutter MM. Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data. Surg Endosc 2008; 22:2554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schauer P, Ikramuddin S, Hamad G, Gourash W. The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg Endosc 2003; 17:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up. Obes Surg 2000; 10:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carlin AM, Zeni TM, English WJ, et al. The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity. Ann Surg 2013; 257:791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aurora AR, Khaitan L, Saber AA. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients. Surg Endosc 2012; 26:1509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dick A, Byrne TK, Baker M, et al. Gastrointestinal bleeding after gastric bypass surgery: nuisance or catastrophe? Surg Obes Relat Dis 2010; 6:643.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sudan R, Maciejewski ML, Wilk AR, et al. Comparative effectiveness of primary bariatric operations in the United States. Surg Obes Relat Dis 2017; 13:826.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maciejewski ML, Winegar DA, Farley JF, et al. Risk stratification of serious adverse events after gastric bypass in the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2012; 8:671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yashkov Y, Bordan N, Torres A, et al. SADI-S 250 vs Roux-en-Y Duodenal Switch (RY-DS): Results of 5-Year Observational Study. Obes Surg 2021; 31:570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLaren DS. Longevity and gender. Science 1988; 241:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robertson AGN, Wiggins T, Robertson FP, et al. Perioperative mortality in bariatric surgery: meta-analysis. Br J Surg 2021; 108:892.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dimick JB, Welch HG, Birkmeyer JD. Surgical mortality as an indicator of hospital quality: the problem with small sample size. JAMA 2004; 292:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verhoeff K, Mocanu V, Jogiat U, et al. Patient Selection and 30-Day Outcomes of SADI-S Compared to RYGB: a Retrospective Cohort Study of 47,375 Patients. Obes Surg 2022; 32:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA 2005; 294:1909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Powers KA, Rehrig ST, Jones DB. Financial impact of obesity and bariatric surgery. Med Clin North Am 2007; 91:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saunders JK, Ballantyne GH, Belsley S, et al. 30-day readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypass. Obes Surg 2007; 17:1171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pratt GM, Learn CA, Hughes GD, et al. Demographics and outcomes at American Society for Metabolic and Bariatric Surgery Centers of Excellence. Surg Endosc 2009; 23:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen SY, Stem M, Schweitzer MA, et al. Assessment of postdischarge complications after bariatric surgery: A National Surgical Quality Improvement Program analysis. Surgery 2015; 158:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Neill SM, Needleman B, Narula V, et al. An analysis of readmission trends by urgency and race/ethnicity in the MBSAQIP registry, 2015-2018. Surg Obes Relat Dis 2022; 18:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berger ER, Huffman KM, Fraker T, et al. Prevalence and Risk Factors for Bariatric Surgery Readmissions: Findings From 130,007 Admissions in the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Ann Surg 2018; 267:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Telem DA, Yang J, Altieri M, et al. Rates and Risk Factors for Unplanned Emergency Department Utilization and Hospital Readmission Following Bariatric Surgery. Ann Surg 2016; 263:956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Docimo S, Yang J, Zhang X, et al. One anastomosis gastric bypass versus Roux-en-Y gastric bypass: a 30-day follow-up review. Surg Endosc 2022; 36:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masoomi H, Nguyen NT, Stamos MJ, Smith BR. Overview of outcomes of laparoscopic and open Roux-en-Y gastric bypass in the United States. Surg Technol Int 2012; 22:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Novitsky YW, Litwin DE, Callery MP. The net immunologic advantage of laparoscopic surgery. Surg Endosc 2004; 18:1411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001; 234:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leivonen MK, Juuti A, Jaser N, Mustonen H. Laparoscopic sleeve gastrectomy in patients over 59 years: early recovery and 12-month follow-up. Obes Surg 2011; 21:1180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones KB Jr, Afram JD, Benotti PN, et al. Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25,000 open cases and the major laparoscopic bariatric reported series. Obes Surg 2006; 16:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith MD, Patterson E, Wahed AS, et al. Relationship between surgeon volume and adverse outcomes after RYGB in Longitudinal Assessment of Bariatric Surgery (LABS) study. Surg Obes Relat Dis 2010; 6:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Luca M, Piatto G, Merola G, et al. IFSO Update Position Statement on One Anastomosis Gastric Bypass (OAGB). Obes Surg 2021; 31:3251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clapp B, Janik MR, El Badaoui J, et al. Five-Year Analysis of the MBSAQIP Database: Are We Getting Better? J Am Coll Surg 2022; 234:1211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Encinosa WE, Bernard DM, Du D, Steiner CA. Recent improvements in bariatric surgery outcomes. Med Care 2009; 47:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Minhem MA, Sarkis SF, Safadi BY, et al. Comparison of Early Morbidity and Mortality Between Sleeve Gastrectomy and Gastric Bypass in High-Risk Patients for Liver Disease: Analysis of American College of Surgeons National Surgical Quality Improvement Program. Obes Surg 2018; 28:2844.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Obes Surg 2023; 33:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arterburn D, Livingston EH, Schifftner T, et al. Predictors of long-term mortality after bariatric surgery performed in Veterans Affairs medical centers. Arch Surg 2009; 144:914.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stephens DJ, Saunders JK, Belsley S, et al. Short-term outcomes for super-super obese (BMI &gt; or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass. Surg Obes Relat Dis 2008; 4:408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ballantyne GH, Svahn J, Capella RF, et al. Predictors of prolonged hospital stay following open and laparoscopic gastric bypass for morbid obesity: body mass index, length of surgery, sleep apnea, asthma, and the metabolic syndrome. Obes Surg 2004; 14:1042.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tiwari MM, Goede MR, Reynoso JF, et al. Differences in outcomes of laparoscopic gastric bypass. Surg Obes Relat Dis 2011; 7:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cawley J, Sweeney MJ, Kurian M, et al. Predicting complications after bariatric surgery using obesity-related co-morbidities. Obes Surg 2007; 17:1451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Topart P, Becouarn G, Ritz P. Comparative early outcomes of three laparoscopic bariatric procedures: sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis 2012; 8:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Helmiö M, Victorzon M, Ovaska J, et al. SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surg Endosc 2012; 26:2521.
          </a>
         </li>
         <li class="breakAll">
          Jones SB, Jones DB. Obesity Surgery: Patient Safety and Best Practices, Ciné-Med, Inc., Woodbury, CT 2008.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagner M, Deitel M, Kalberer TL, et al. The Second International Consensus Summit for Sleeve Gastrectomy, March 19-21, 2009. Surg Obes Relat Dis 2009; 5:476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lalor PF, Tucker ON, Szomstein S, Rosenthal RJ. Complications after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 2008; 4:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg 2005; 15:1469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006; 16:1450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg 2006; 16:1138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc 2007; 21:1810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamoui N, Anthone GJ, Kaufman HS, Crookes PF. Sleeve gastrectomy in the high-risk patient. Obes Surg 2006; 16:1445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armstrong J, O'Malley SP. Outcomes of sleeve gastrectomy for morbid obesity: a safe and effective procedure? Int J Surg 2010; 8:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trelles N, Gagner M. Sleeve gastrectomy. Operative Techniques in General Surgery 2007; 9:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Higgins RM, Helm M, Gould JC, Kindel TL. Preoperative immobility significantly impacts the risk of postoperative complications in bariatric surgery patients. Surg Obes Relat Dis 2018; 14:842.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carter J, Chang J, Birriel TJ, et al. ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery. Surg Obes Relat Dis 2021; 17:1956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Nieuwenhove Y, Dambrauskas Z, Campillo-Soto A, et al. Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg 2011; 146:1300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cassie S, Menezes C, Birch DW, et al. Effect of preoperative weight loss in bariatric surgical patients: a systematic review. Surg Obes Relat Dis 2011; 7:760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou J, Du R, Wang L, et al. The Application of Enhanced Recovery After Surgery (ERAS) for Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis. Obes Surg 2021; 31:1321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Budiansky AS, Margarson MP, Eipe N. Acute pain management in morbid obesity - an evidence based clinical update. Surg Obes Relat Dis 2017; 13:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belcaid I, Eipe N. Perioperative Pain Management in Morbid Obesity. Drugs 2019; 79:1163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stenberg E, Dos Reis Falcão LF, O'Kane M, et al. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update. World J Surg 2022; 46:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kindel TL, Ganga RR, Baker JW, et al. American Society for Metabolic and Bariatric Surgery: Preoperative Care Pathway for Laparoscopic Roux-en-Y Gastric Bypass. Surg Obes Relat Dis 2021; 17:1529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dang JT, Szeto VG, Elnahas A, et al. Canadian consensus statement: enhanced recovery after surgery in bariatric surgery. Surg Endosc 2020; 34:1366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Telem DA, Gould J, Pesta C, et al. American Society for Metabolic and Bariatric Surgery: care pathway for laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 2017; 13:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Telem DA, Majid SF, Powers K, et al. Assessing national provision of care: variability in bariatric clinical care pathways. Surg Obes Relat Dis 2017; 13:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz ML, Drew RL, Andersen JN. Induction of pneumoperitoneum in morbidly obese patients. Obes Surg 2003; 13:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madan AK, Taddeucci RJ, Harper JL, Tichansky DS. Initial trocar placement and abdominal insufflation in laparoscopic bariatric surgery. J Surg Res 2008; 148:210.
          </a>
         </li>
         <li class="breakAll">
          Jones DB, Maithel SK, Schneider BE, Hart B. Atlas of Minimally Invasive Surgery, Ciné-Med, Woodbury, CT 2006.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahmad G, Duffy JM, Phillips K, Watson A. Laparoscopic entry techniques. Cochrane Database Syst Rev 2008; :CD006583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peters TG, Steinmetz SR, Cowan GS Jr. Splenic injury and repair during bariatric surgical procedures. South Med J 1990; 83:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huerta S, Li Z, Livingston EH. Outcome of portal injuries following bariatric operations. Obes Surg 2006; 16:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Khyatt W, Thomas JD, Humes DJ, Lobo DN. Intestinal ischemia following laparoscopic surgery: a case series. J Med Case Rep 2013; 7:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schorr RT. Laparoscopic upper abdominal operations and mesenteric infarction. J Laparoendosc Surg 1995; 5:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell PC, Jamieson GG. Coeliac axis and mesenteric arterial thrombosis following laparoscopic Nissen fundoplication. Aust N Z J Surg 1994; 64:728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hasson HM, Galanopoulos C, Langerman A. Ischemic necrosis of small bowel following laparoscopic surgery. JSLS 2004; 8:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitchell MT, Gasparaitis AE, Alverdy JC. Imaging findings in Roux-en-O and other misconstructions: rare but serious complications of Roux-en-Y gastric bypass surgery. AJR Am J Roentgenol 2008; 190:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melinek J, Livingston E, Cortina G, Fishbein MC. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Pathol Lab Med 2002; 126:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000; 232:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westling A, Gustavsson S. Laparoscopic vs open Roux-en-Y gastric bypass: a prospective, randomized trial. Obes Surg 2001; 11:284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen NT, Ho HS, Palmer LS, Wolfe BM. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg 2000; 191:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients--what have we learned? Obes Surg 2000; 10:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papasavas PK, Hayetian FD, Caushaj PF, et al. Outcome analysis of laparoscopic Roux-en-Y gastric bypass for morbid obesity. The first 116 cases. Surg Endosc 2002; 16:1653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luján JA, Hernandez Q, Frutos MD, et al. Laparoscopic gastric bypass in the treatment of morbid obesity. Preliminary results of a new technique. Surg Endosc 2002; 16:1658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mehran A, Szomstein S, Zundel N, Rosenthal R. Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2003; 13:842.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen NT, Rivers R, Wolfe BM. Early gastrointestinal hemorrhage after laparoscopic gastric bypass. Obes Surg 2003; 13:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stroh C, Köckerling F, Weiner R, et al. Are there gender-specific aspects of sleeve gastrectomy-data analysis from the quality assurance study of surgical treatment of obesity in Germany. Obes Surg 2012; 22:1214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gentileschi P, Camperchioli I, D'Ugo S, et al. Staple-line reinforcement during laparoscopic sleeve gastrectomy using three different techniques: a randomized trial. Surg Endosc 2012; 26:2623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dapri G, Cadière GB, Himpens J. Reinforcing the staple line during laparoscopic sleeve gastrectomy: prospective randomized clinical study comparing three different techniques. Obes Surg 2010; 20:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim RB, Blackburn GL, Jones DB. Benchmarking best practices in weight loss surgery. Curr Probl Surg 2010; 47:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider BE, Villegas L, Blackburn GL, et al. Laparoscopic gastric bypass surgery: outcomes. J Laparoendosc Adv Surg Tech A 2003; 13:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim J, Azagury D, Eisenberg D, et al. ASMBS position statement on prevention, detection, and treatment of gastrointestinal leak after gastric bypass and sleeve gastrectomy, including the roles of imaging, surgical exploration, and nonoperative management. Surg Obes Relat Dis 2015; 11:739.
          </a>
         </li>
         <li class="breakAll">
          Gonzalez R, Murr MM. Anastomotic leaks following gastric bypass surgery. In: Weight Loss Surgery: A Multidisciplinary Approach, Rosenthal RJ, Jones DB (Eds), Matrix Medical Communications, Edgemont, PA 2008. p.369.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith MD, Adeniji A, Wahed AS, et al. Technical factors associated with anastomotic leak after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2015; 11:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar SB, Hamilton BC, Wood SG, et al. Is laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass? a comparison of 30-day complications using the MBSAQIP data registry. Surg Obes Relat Dis 2018; 14:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alizadeh RF, Li S, Inaba C, et al. Risk Factors for Gastrointestinal Leak after Bariatric Surgery: MBASQIP Analysis. J Am Coll Surg 2018; 227:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagner M, Kemmeter P. Comparison of laparoscopic sleeve gastrectomy leak rates in five staple-line reinforcement options: a systematic review. Surg Endosc 2020; 34:396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hedberg J, Sundström J, Sundbom M. Duodenal switch versus Roux-en-Y gastric bypass for morbid obesity: systematic review and meta-analysis of weight results, diabetes resolution and early complications in single-centre comparisons. Obes Rev 2014; 15:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamilton EC, Sims TL, Hamilton TT, et al. Clinical predictors of leak after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Endosc 2003; 17:679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sims TL, Mullican MA, Hamilton EC, et al. Routine upper gastrointestinal Gastrografin swallow after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2003; 13:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madan AK, Stoecklein HH, Ternovits CA, et al. Predictive value of upper gastrointestinal studies versus clinical signs for gastrointestinal leaks after laparoscopic gastric bypass. Surg Endosc 2007; 21:194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raman R, Raman B, Raman P, et al. Abnormal findings on routine upper GI series following laparoscopic Roux-en-Y gastric bypass. Obes Surg 2007; 17:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doraiswamy A, Rasmussen JJ, Pierce J, et al. The utility of routine postoperative upper GI series following laparoscopic gastric bypass. Surg Endosc 2007; 21:2159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White S, Han SH, Lewis C, et al. Selective approach to use of upper gastroesophageal imaging study after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2008; 4:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thodiyil PA, Yenumula P, Rogula T, et al. Selective nonoperative management of leaks after gastric bypass: lessons learned from 2675 consecutive patients. Ann Surg 2008; 248:782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonzalez R, Sarr MG, Smith CD, et al. Diagnosis and contemporary management of anastomotic leaks after gastric bypass for obesity. J Am Coll Surg 2007; 204:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marshall JS, Srivastava A, Gupta SK, et al. Roux-en-Y gastric bypass leak complications. Arch Surg 2003; 138:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durak E, Inabnet WB, Schrope B, et al. Incidence and management of enteric leaks after gastric bypass for morbid obesity during a 10-year period. Surg Obes Relat Dis 2008; 4:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merrifield BF, Lautz D, Thompson CC. Endoscopic repair of gastric leaks after Roux-en-Y gastric bypass: a less invasive approach. Gastrointest Endosc 2006; 63:710.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fukumoto R, Orlina J, McGinty J, Teixeira J. Use of Polyflex stents in treatment of acute esophageal and gastric leaks after bariatric surgery. Surg Obes Relat Dis 2007; 3:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mennigen R, Senninger N, Laukoetter MG. Novel treatment options for perforations of the upper gastrointestinal tract: endoscopic vacuum therapy and over-the-scope clips. World J Gastroenterol 2014; 20:7767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Souto-Rodríguez R, Alvarez-Sánchez MV. Endoluminal solutions to bariatric surgery complications: A review with a focus on technical aspects and results. World J Gastrointest Endosc 2017; 9:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abou Rached A, Basile M, El Masri H. Gastric leaks post sleeve gastrectomy: review of its prevention and management. World J Gastroenterol 2014; 20:13904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shikora SA, Kim JJ, Tarnoff ME. Reinforcing gastric staple-lines with bovine pericardial strips may decrease the likelihood of gastric leak after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2003; 13:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu CD, Glantz GJ, Livingston EH. Fibrin glue as a sealant for high-risk anastomosis in surgery for morbid obesity. Obes Surg 2003; 13:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shikora SA. The use of staple-line reinforcement during laparoscopic gastric bypass. Obes Surg 2004; 14:1313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shikora SA, Kim JJ, Tarnoff ME. Comparison of permanent and nonpermanent staple line buttressing materials for linear gastric staple lines during laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2008; 4:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fullum TM, Aluka KJ, Turner PL. Decreasing anastomotic and staple line leaks after laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2009; 23:1403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller KA, Pump A. Use of bioabsorbable staple reinforcement material in gastric bypass: a prospective randomized clinical trial. Surg Obes Relat Dis 2007; 3:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sapala JA, Wood MH, Schuhknecht MP. Anastomotic leak prophylaxis using a vapor-heated fibrin sealant: report on 738 gastric bypass patients. Obes Surg 2004; 14:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Livingston EH, Liu CY, Glantz G, Li Z. Characteristics of bariatric surgery in an integrated VA Health Care System: follow-up and outcomes. J Surg Res 2003; 109:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang Z, Dai X, Xie H, et al. The efficacy of staple line reinforcement during laparoscopic sleeve gastrectomy: A meta-analysis of randomized controlled trials. Int J Surg 2016; 25:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baltasar A, Serra C, Pérez N, et al. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg 2005; 15:1124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frezza EE, Reddy S, Gee LL, Wachtel MS. Complications after sleeve gastrectomy for morbid obesity. Obes Surg 2009; 19:684.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Consten EC, Gagner M, Pomp A, Inabnet WB. Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane. Obes Surg 2004; 14:1360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pories WJ, van Rij AM, Burlingham BT, et al. Prophylactic cefazolin in gastric bypass surgery. Surgery 1981; 90:426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Csendes A, Burgos AM, Altuve J, Bonacic S. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg 2009; 19:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg 2005; 15:408.
          </a>
         </li>
         <li class="breakAll">
          Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion: two decades of experience. In: Update: Surgery for the Morbidly Obese Patient, Deitel M, Cowan GSM (Eds), FD-Communications, Toronto 2000. p.227.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azagury DE, Abu Dayyeh BK, Greenwalt IT, Thompson CC. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy 2011; 43:950.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parikh A, Alley JB, Peterson RM, et al. Management options for symptomatic stenosis after laparoscopic vertical sleeve gastrectomy in the morbidly obese. Surg Endosc 2012; 26:738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khrucharoen U, Weitzner ZN, Chen Y, Dutson EP. Incidence and risk factors for early gastrojejunostomy anastomotic stricture requiring endoscopic intervention following laparoscopic Roux-en-Y gastric bypass: a MBSAQIP analysis. Surg Endosc 2022; 36:3833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ximenes MA, Baroni RH, Trindade RM, et al. Petersen's hernia as a complication of bariatric surgery: CT findings. Abdom Imaging 2011; 36:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shimizu H, Maia M, Kroh M, et al. Surgical management of early small bowel obstruction after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2013; 9:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khrucharoen U, Juo YY, Wongpongsalee T, et al. Risk factors for readmission for early small bowel obstruction following laparoscopic Roux-en-Y gastric bypass: an MBSAQIP analysis. Surg Obes Relat Dis 2021; 17:1041.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrucciani N, Martini F, Kassir R, et al. Internal Hernia After One Anastomosis Gastric Bypass (OAGB): Lessons Learned from a Retrospective Series of 3368 Consecutive Patients Undergoing OAGB with a Biliopancreatic Limb of 150 cm. Obes Surg 2021; 31:2537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skrekas G, Antiochos K, Stafyla VK. Laparoscopic gastric greater curvature plication: results and complications in a series of 135 patients. Obes Surg 2011; 21:1657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gravante G, Araco A, Araco F, et al. Laparoscopic adjustable gastric bandings: a prospective randomized study of 400 operations performed with 2 different devices. Arch Surg 2007; 142:958.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spivak H, Favretti F. Avoiding postoperative complications with the LAP-BAND system. Am J Surg 2002; 184:31S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagner M, Gentileschi P, de Csepel J, et al. Laparoscopic reoperative bariatric surgery: experience from 27 consecutive patients. Obes Surg 2002; 12:254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shen R, Ren CJ. Removal of peri-gastric fat prevents acute obstruction after Lap-Band surgery. Obes Surg 2004; 14:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaheen O, Siejka J, Thatigotla B, Pham DT. A systematic review of portomesenteric vein thrombosis after sleeve gastrectomy. Surg Obes Relat Dis 2017; 13:1422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shoar S, Saber AA, Rubenstein R, et al. Portomesentric and splenic vein thrombosis (PMSVT) after bariatric surgery: a systematic review of 110 patients. Surg Obes Relat Dis 2018; 14:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moon RC, Ghanem M, Teixeira AF, et al. Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study. Surg Obes Relat Dis 2018; 14:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winegar DA, Sherif B, Pate V, DeMaria EJ. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2011; 7:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jamal MH, Corcelles R, Shimizu H, et al. Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. Surg Endosc 2015; 29:376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis 2013; 9:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masoomi H, Buchberg B, Reavis KM, et al. Factors predictive of venous thromboembolism in bariatric surgery. Am Surg 2011; 77:1403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sapala JA, Wood MH, Schuhknecht MP, Sapala MA. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg 2003; 13:819.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haskins IN, Rivas L, Ju T, et al. The association of IVC filter placement with the incidence of postoperative pulmonary embolism following laparoscopic bariatric surgery: an analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Project. Surg Obes Relat Dis 2019; 15:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Becattini C, Agnelli G, Manina G, et al. Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis 2012; 8:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg 2000; 10:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aminian A, Vosburg RW, Altieri MS, et al. The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery. Surg Obes Relat Dis 2022; 18:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birkmeyer NJ, Finks JF, Carlin AM, et al. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery. Arch Surg 2012; 147:994.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caruana JA, Anain PM, Pham DT. The pulmonary embolism risk score system reduces the incidence and mortality of pulmonary embolism after gastric bypass. Surgery 2009; 146:678.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birkmeyer NJ, Finks JF, English WJ, et al. Risks and benefits of prophylactic inferior vena cava filters in patients undergoing bariatric surgery. J Hosp Med 2013; 8:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masoomi H, Reavis KM, Smith BR, et al. Risk factors for acute respiratory failure in bariatric surgery: data from the Nationwide Inpatient Sample, 2006-2008. Surg Obes Relat Dis 2013; 9:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta PK, Gupta H, Kaushik M, et al. Predictors of pulmonary complications after bariatric surgery. Surg Obes Relat Dis 2012; 8:574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huerta S, DeShields S, Shpiner R, et al. Safety and efficacy of postoperative continuous positive airway pressure to prevent pulmonary complications after Roux-en-Y gastric bypass. J Gastrointest Surg 2002; 6:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ballantyne GH, Belsley S, Stephens D, et al. Bariatric surgery: low mortality at a high-volume center. Obes Surg 2008; 18:660.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flum DR, Salem L, Elrod JA, et al. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 2005; 294:1903.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith MD, Patterson E, Wahed AS, et al. Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery. Obes Surg 2011; 21:1687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Owers CE, Abbas Y, Ackroyd R, et al. Perioperative optimization of patients undergoing bariatric surgery. J Obes 2012; 2012:781546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mason EE, Renquist KE, Huang YH, et al. Causes of 30-day bariatric surgery mortality: with emphasis on bypass obstruction. Obes Surg 2007; 17:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagner M, Milone L, Yung E, et al. Causes of early mortality after laparoscopic adjustable gastric banding. J Am Coll Surg 2008; 206:664.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis 2007; 3:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeMaria EJ, Murr M, Byrne TK, et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg 2007; 246:578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen NT, Masoomi H, Laugenour K, et al. Predictive factors of mortality in bariatric surgery: data from the Nationwide Inpatient Sample. Surgery 2011; 150:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Livingston EH, Langert J. The impact of age and Medicare status on bariatric surgical outcomes. Arch Surg 2006; 141:1115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hollenbeak CS, Rogers AM, Barrus B, et al. Surgical volume impacts bariatric surgery mortality: a case for centers of excellence. Surgery 2008; 144:736.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fan VS, Maciejewski ML, Liu C, et al. Comparison of risk adjustment measures based on self-report, administrative data, and pharmacy records to predict clinical outcomes. Health Serv Outcomes Res Methodol 2006; 6:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pope GC, Kautter J, Ellis RP, et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev 2004; 25:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maciejewski ML, Liu CF, Derleth A, et al. The performance of administrative and self-reported measures for risk adjustment of Veterans Affairs expenditures. Health Serv Res 2005; 40:887.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Podnos YD, Jimenez JC, Wilson SE, et al. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg 2003; 138:957.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janata K, Holzer M, Domanovits H, et al. Mortality of patients with pulmonary embolism. Wien Klin Wochenschr 2002; 114:766.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morino M, Toppino M, Forestieri P, et al. Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry. Ann Surg 2007; 246:1002.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haskins IN, Ju T, Whitlock AE, et al. Older Age Confers a Higher Risk of 30-Day Morbidity and Mortality Following Laparoscopic Bariatric Surgery: an Analysis of the Metabolic and Bariatric Surgery Quality Improvement Program. Obes Surg 2018; 28:2745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inabnet WB 3rd, Winegar DA, Sherif B, Sarr MG. Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg 2012; 214:550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varela JE, Hinojosa MW, Nguyen NT. Bariatric surgery outcomes in morbidly obese with the metabolic syndrome at US academic centers. Obes Surg 2008; 18:1273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9:897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan MA, Grinberg R, Johnson S, et al. Perioperative risk factors for 30-day mortality after bariatric surgery: is functional status important? Surg Endosc 2013; 27:1772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohr CJ, Nadzam GS, Curet MJ. Totally robotic Roux-en-Y gastric bypass. Arch Surg 2005; 140:779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohr CJ, Nadzam GS, Alami RS, et al. Totally robotic laparoscopic Roux-en-Y Gastric bypass: results from 75 patients. Obes Surg 2006; 16:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanchez BR, Mohr CJ, Morton JM, et al. Comparison of totally robotic laparoscopic Roux-en-Y gastric bypass and traditional laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005; 1:549.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 87686 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22634116" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Prevalence of adverse intraoperative events during obesity surgery and their sequelae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24374541" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30014238" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Laparoscopic Sleeve Gastrectomy Is Associated with Lower 30-Day Morbidity Versus Laparoscopic Gastric Bypass: an Analysis of the American College of Surgeons NSQIP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22987179" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21865942" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28569357" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Complications Following the Mini/One Anastomosis Gastric Bypass (MGB/OAGB): a Multi-institutional Survey on 2678 Patients with a Mid-term (5 Years) Follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31758474" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : One Anastomosis Gastric Bypass-Mini-Gastric Bypass (OAGB-MGB) Versus Roux-en-Y Gastric Bypass (RYGB)-a Mid-Term Cohort Study with 612 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35352174" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Single anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S): experience from a high-bariatric volume center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32240495" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Single Versus Double-Anastomosis Duodenal Switch: Single-Site Comparative Cohort Study in 440 Consecutive Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18806945" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12457218" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10929154" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23470577" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22179470" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21111381" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Gastrointestinal bleeding after gastric bypass surgery: nuisance or catastrophe?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28236529" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Comparative effectiveness of primary bariatric operations in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23058451" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Risk stratification of serious adverse events after gastric bypass in the Bariatric Outcomes Longitudinal Database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33047290" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : SADI-S 250 vs Roux-en-Y Duodenal Switch (RY-DS): Results of 5-Year Observational Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3393905" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Longevity and gender.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34297806" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Perioperative mortality in bariatric surgery: meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15315999" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Surgical mortality as an indicator of hospital quality: the problem with small sample size.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35445967" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Patient Selection and 30-Day Outcomes of SADI-S Compared to RYGB: a Retrospective Cohort Study of 47,375 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16234497" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Trends in bariatric surgical procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17509381" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Financial impact of obesity and bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18074490" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : 30-day readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19184200" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Demographics and outcomes at American Society for Metabolic and Bariatric Surgery Centers of Excellence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26096563" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Assessment of postdischarge complications after bariatric surgery: A National Surgical Quality Improvement Program analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34789421" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : An analysis of readmission trends by urgency and race/ethnicity in the MBSAQIP registry, 2015-2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27849660" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Prevalence and Risk Factors for Bariatric Surgery Readmissions: Findings From 130,007 Admissions in the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26727087" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Rates and Risk Factors for Unplanned Emergency Department Utilization and Hospital Readmission Following Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33591446" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : One anastomosis gastric bypass versus Roux-en-Y gastric bypass: a 30-day follow-up review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23065805" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Overview of outcomes of laparoscopic and open Roux-en-Y gastric bypass in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15791361" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The net immunologic advantage of laparoscopic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11524581" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21625908" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Laparoscopic sleeve gastrectomy in patients over 59 years: early recovery and 12-month follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16756731" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25,000 open cases and the major laparoscopic bariatric reported series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19969507" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Relationship between surgeon volume and adverse outcomes after RYGB in Longitudinal Assessment of Bariatric Surgery (LABS) study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33939059" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : IFSO Update Position Statement on One Anastomosis Gastric Bypass (OAGB).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35703820" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Five-Year Analysis of the MBSAQIP Database: Are We Getting Better?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19318997" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Recent improvements in bariatric surgery outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19641201" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Perioperative safety in the longitudinal assessment of bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29696572" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Comparison of Early Morbidity and Mortality Between Sleeve Gastrectomy and Gastric Bypass in High-Risk Patients for Liver Disease: Analysis of American College of Surgeons National Surgical Quality Improvement Program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36336720" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19841358" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Predictors of long-term mortality after bariatric surgery performed in Veterans Affairs medical centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18243060" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Short-term outcomes for super-super obese (BMI&gt;or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15487110" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Predictors of prolonged hospital stay following open and laparoscopic gastric bypass for morbid obesity: body mass index, length of surgery, sleep apnea, asthma, and the metabolic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21459686" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Differences in outcomes of laparoscopic gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18219771" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Predicting complications after bariatric surgery using obesity-related co-morbidities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21803660" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Comparative early outcomes of three laparoscopic bariatric procedures: sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22476829" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22476829" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19632647" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The Second International Consensus Summit for Sleeve Gastrectomy, March 19-21, 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17981515" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Complications after laparoscopic sleeve gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16354529" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17132410" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16989696" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17356932" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17132409" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Sleeve gastrectomy in the high-risk patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19944193" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Outcomes of sleeve gastrectomy for morbid obesity: a safe and effective procedure?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Sleeve gastrectomy
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29599072" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Preoperative immobility significantly impacts the risk of postoperative complications in bariatric surgery patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34629296" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22106323" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21978748" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Effect of preoperative weight loss in bariatric surgical patients: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33420977" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : The Application of Enhanced Recovery After Surgery (ERAS) for Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27771314" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Acute pain management in morbid obesity - an evidence based clinical update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31256367" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Perioperative Pain Management in Morbid Obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34984504" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34148848" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : American Society for Metabolic and Bariatric Surgery: Preoperative Care Pathway for Laparoscopic Roux-en-Y Gastric Bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31209605" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Canadian consensus statement: enhanced recovery after surgery in bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28416400" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : American Society for Metabolic and Bariatric Surgery: care pathway for laparoscopic sleeve gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27887932" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Assessing national provision of care: variability in bariatric clinical care pathways.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12935362" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Induction of pneumoperitoneum in morbidly obese patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18262554" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Initial trocar placement and abdominal insufflation in laparoscopic bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18262554" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Initial trocar placement and abdominal insufflation in laparoscopic bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18425957" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Laparoscopic entry techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2406932" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Splenic injury and repair during bariatric surgical procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16417768" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Outcome of portal injuries following bariatric operations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23336390" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Intestinal ischemia following laparoscopic surgery: a case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8746991" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Laparoscopic upper abdominal operations and mesenteric infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7945076" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Coeliac axis and mesenteric arterial thrombosis following laparoscopic Nissen fundoplication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15119662" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Ischemic necrosis of small bowel following laparoscopic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18212222" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Imaging findings in Roux-en-O and other misconstructions: rare but serious complications of Roux-en-Y gastric bypass surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12204059" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Autopsy findings following gastric bypass surgery for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10998650" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11433902" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Laparoscopic vs open Roux-en-Y gastric bypass: a prospective, randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10945358" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : A comparison study of laparoscopic versus open gastric bypass for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11175957" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients--what have we learned?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12239643" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Outcome analysis of laparoscopic Roux-en-Y gastric bypass for morbid obesity. The first 116 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12140634" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Laparoscopic gastric bypass in the treatment of morbid obesity. Preliminary results of a new technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14738667" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12630615" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Early gastrointestinal hemorrhage after laparoscopic gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22664912" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Are there gender-specific aspects of sleeve gastrectomy-data analysis from the quality assurance study of surgical treatment of obesity in Germany.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22441975" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Staple-line reinforcement during laparoscopic sleeve gastrectomy using three different techniques: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20012507" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Reinforcing the staple line during laparoscopic sleeve gastrectomy: prospective randomized clinical study comparing three different techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20103467" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Benchmarking best practices in weight loss surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14561253" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Laparoscopic gastric bypass surgery: outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26071849" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : ASMBS position statement on prevention, detection, and treatment of gastrointestinal leak after gastric bypass and sleeve gastrectomy, including the roles of imaging, surgical exploration, and nonoperative management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26071849" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : ASMBS position statement on prevention, detection, and treatment of gastrointestinal leak after gastric bypass and sleeve gastrectomy, including the roles of imaging, surgical exploration, and nonoperative management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25595919" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Technical factors associated with anastomotic leak after Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29519658" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Is laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass? a comparison of 30-day complications using the MBSAQIP data registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29605723" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Risk Factors for Gastrointestinal Leak after Bariatric Surgery: MBASQIP Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30993513" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Comparison of laparoscopic sleeve gastrectomy leak rates in five staple-line reinforcement options: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24666623" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Duodenal switch versus Roux-en-Y gastric bypass for morbid obesity: systematic review and meta-analysis of weight results, diabetes resolution and early complications in single-centre comparisons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12618940" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Clinical predictors of leak after laparoscopic Roux-en-Y gastric bypass for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12630616" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Routine upper gastrointestinal Gastrografin swallow after laparoscopic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17122986" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Predictive value of upper gastrointestinal studies versus clinical signs for gastrointestinal leaks after laparoscopic gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17546837" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Abnormal findings on routine upper GI series following laparoscopic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17514398" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : The utility of routine postoperative upper GI series following laparoscopic gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18065294" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Selective approach to use of upper gastroesophageal imaging study after laparoscopic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18948805" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Selective nonoperative management of leaks after gastric bypass: lessons learned from 2675 consecutive patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17189112" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Diagnosis and contemporary management of anastomotic leaks after gastric bypass for obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12742956" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Roux-en-Y gastric bypass leak complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18407803" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Incidence and management of enteric leaks after gastric bypass for morbid obesity during a 10-year period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16564884" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Endoscopic repair of gastric leaks after Roux-en-Y gastric bypass: a less invasive approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17196440" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Use of Polyflex stents in treatment of acute esophageal and gastric leaks after bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24976714" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Novel treatment options for perforations of the upper gastrointestinal tract: endoscopic vacuum therapy and over-the-scope clips.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28360973" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Endoluminal solutions to bariatric surgery complications: A review with a focus on technical aspects and results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25320526" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Gastric leaks post sleeve gastrectomy: review of its prevention and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12630611" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Reinforcing gastric staple-lines with bovine pericardial strips may decrease the likelihood of gastric leak after laparoscopic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12630612" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Fibrin glue as a sealant for high-risk anastomosis in surgery for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15603644" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : The use of staple-line reinforcement during laparoscopic gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18586575" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Comparison of permanent and nonpermanent staple line buttressing materials for linear gastric staple lines during laparoscopic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19263134" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Decreasing anastomotic and staple line leaks after laparoscopic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17567538" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Use of bioabsorbable staple reinforcement material in gastric bypass: a prospective randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14980031" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Anastomotic leak prophylaxis using a vapor-heated fibrin sealant: report on 738 gastric bypass patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12643855" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Characteristics of bariatric surgery in an integrated VA Health Care System: follow-up and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26700201" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : The efficacy of staple line reinforcement during laparoscopic sleeve gastrectomy: A meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16197783" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18923879" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Complications after sleeve gastrectomy for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15603652" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7020141" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Prophylactic cefazolin in gastric bypass surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18581192" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15826478" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : The biliopancreatic diversion with the duodenal switch: results beyond 10 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15826478" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : The biliopancreatic diversion with the duodenal switch: results beyond 10 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21997722" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22044967" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Management options for symptomatic stenosis after laparoscopic vertical sleeve gastrectomy in the morbidly obese.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34471978" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Incidence and risk factors for early gastrojejunostomy anastomotic stricture requiring endoscopic intervention following laparoscopic Roux-en-Y gastric bypass: a MBSAQIP analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20473666" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Petersen's hernia as a complication of bariatric surgery: CT findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22796431" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Surgical management of early small bowel obstruction after laparoscopic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33965351" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Risk factors for readmission for early small bowel obstruction following laparoscopic Roux-en-Y gastric bypass: an MBSAQIP analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33830446" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Internal Hernia After One Anastomosis Gastric Bypass (OAGB): Lessons Learned from a Retrospective Series of 3368 Consecutive Patients Undergoing OAGB with a Biliopancreatic Limb of 150 cm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21898042" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Laparoscopic gastric greater curvature plication: results and complications in a series of 135 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17938309" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Laparoscopic adjustable gastric bandings: a prospective randomized study of 400 operations performed with 2 different devices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12527348" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Avoiding postoperative complications with the LAP-BAND system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11975224" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Laparoscopic reoperative bariatric surgery: experience from 27 consecutive patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15027437" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Removal of peri-gastric fat prevents acute obstruction after Lap-Band surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28526434" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : A systematic review of portomesenteric vein thrombosis after sleeve gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29111221" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Portomesentric and splenic vein thrombosis (PMSVT) after bariatric surgery: a systematic review of 110 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29174885" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21421182" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24986019" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23769113" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22127099" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Factors predictive of venous thromboembolism in bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14738663" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30514668" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : The association of IVC filter placement with the incidence of postoperative pulmonary embolism following laparoscopic bariatric surgery: an analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22014482" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10715636" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : Current practices in the prophylaxis of venous thromboembolism in bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34896011" id="rid158" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          159 : The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23165612" id="rid159" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          160 : Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19789027" id="rid160" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          161 : The pulmonary embolism risk score system reduces the incidence and mortality of pulmonary embolism after gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23401464" id="rid161" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          162 : Risks and benefits of prophylactic inferior vena cava filters in patients undergoing bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22534604" id="rid162" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          163 : Risk factors for acute respiratory failure in bariatric surgery: data from the Nationwide Inpatient Sample, 2006-2008.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21719358" id="rid163" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          164 : Predictors of pulmonary complications after bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12022987" id="rid164" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          165 : Safety and efficacy of postoperative continuous positive airway pressure to prevent pulmonary complications after Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18386110" id="rid165" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          166 : Bariatric surgery: low mortality at a high-volume center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16234496" id="rid166" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          167 : Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21866378" id="rid167" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          168 : Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22829998" id="rid168" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          169 : Perioperative optimization of patients undergoing bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17355762" id="rid169" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          170 : Causes of 30-day bariatric surgery mortality: with emphasis on bypass obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18387472" id="rid170" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          171 : Causes of early mortality after laparoscopic adjustable gastric banding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17386394" id="rid171" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          172 : Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17893494" id="rid172" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          173 : Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21801970" id="rid173" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          174 : Predictive factors of mortality in bariatric surgery: data from the Nationwide Inpatient Sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17116805" id="rid174" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          175 : The impact of age and Medicare status on bariatric surgical outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19081015" id="rid175" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          176 : Surgical volume impacts bariatric surgery mortality: a case for centers of excellence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid176" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          177 : Comparison of risk adjustment measures based on self-report, administrative data, and pharmacy records to predict clinical outcomes
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15493448" id="rid177" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          178 : Risk adjustment of Medicare capitation payments using the CMS-HCC model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15960696" id="rid178" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          179 : The performance of administrative and self-reported measures for risk adjustment of Veterans Affairs expenditures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12963651" id="rid179" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          180 : Complications after laparoscopic gastric bypass: a review of 3464 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12416281" id="rid180" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          181 : Mortality of patients with pulmonary embolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18043102" id="rid181" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          182 : Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29663253" id="rid182" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          183 : Older Age Confers a Higher Risk of 30-Day Morbidity and Mortality Following Laparoscopic Bariatric Surgery: an Analysis of the Metabolic and Bariatric Surgery Quality Improvement Program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22321517" id="rid183" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          184 : Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18431609" id="rid184" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          185 : Bariatric surgery outcomes in morbidly obese with the metabolic syndrome at US academic centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21782772" id="rid185" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          186 : Increased perioperative mortality following bariatric surgery among patients with cirrhosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23299129" id="rid186" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          187 : Perioperative risk factors for 30-day mortality after bariatric surgery: is functional status important?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16103289" id="rid187" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          188 : Totally robotic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16756726" id="rid188" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          189 : Totally robotic laparoscopic Roux-en-Y Gastric bypass: results from 75 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16925289" id="rid189" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          190 : Comparison of totally robotic laparoscopic Roux-en-Y gastric bypass and traditional laparoscopic Roux-en-Y gastric bypass.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
